Delaware | 36-3871531 | |||||||||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Title of each class | Trading Symbols | Name of each exchange on which registered | ||||||
Common Stock, par value $.01 per share | ALL | New York Stock Exchange Chicago Stock Exchange | ||||||
5.100% Fixed-to-Floating Rate Subordinated Debentures due 2053 | ALL.PR.B | New York Stock Exchange | ||||||
Depositary Shares represent 1/1,000th of a share of 5.100% Noncumulative Preferred Stock, Series H | ALL PR H | New York Stock Exchange | ||||||
Depositary Shares represent 1/1,000th of a share of 4.750% Noncumulative Preferred Stock, Series I | ALL PR I | New York Stock Exchange |
Large accelerated filer | ☒ | Accelerated filer | ☐ | ||||||||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||||
Emerging growth company | ☐ |
Part I Financial Information | Page | |||||||
Item 1. Financial Statements (unaudited) as of March 31, 2023 and December 31, 2022 and for the Three Month Periods Ended March 31, 2023 and 2022 | ||||||||
Property-Liability Operations | ||||||||
Segment results | ||||||||
Part II Other Information | ||||||||
($ in millions, except per share data) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Revenues | ||||||||||||||
Property and casualty insurance premiums | $ | 12,173 | $ | 10,981 | ||||||||||
Accident and health insurance premiums and contract charges | 463 | 468 | ||||||||||||
Other revenue | 561 | 560 | ||||||||||||
Net investment income | 575 | 594 | ||||||||||||
Net gains (losses) on investments and derivatives | 14 | (267) | ||||||||||||
Total revenues | 13,786 | 12,336 | ||||||||||||
Costs and expenses | ||||||||||||||
Property and casualty insurance claims and claims expense | 10,326 | 7,822 | ||||||||||||
Accident, health and other policy benefits | 265 | 268 | ||||||||||||
Amortization of deferred policy acquisition costs | 1,744 | 1,608 | ||||||||||||
Operating costs and expenses | 1,716 | 1,902 | ||||||||||||
Pension and other postretirement remeasurement (gains) losses | (53) | (247) | ||||||||||||
Restructuring and related charges | 27 | 12 | ||||||||||||
Amortization of purchased intangibles | 81 | 87 | ||||||||||||
Interest expense | 86 | 83 | ||||||||||||
Total costs and expenses | 14,192 | 11,535 | ||||||||||||
(Loss) income from operations before income tax expense | (406) | 801 | ||||||||||||
Income tax (benefit) expense | (85) | 151 | ||||||||||||
Net (loss) income | (321) | 650 | ||||||||||||
Less: Net loss attributable to noncontrolling interest | (1) | (10) | ||||||||||||
Net (loss) income attributable to Allstate | (320) | 660 | ||||||||||||
Less: Preferred stock dividends | 26 | 26 | ||||||||||||
Net (loss) income applicable to common shareholders | $ | (346) | $ | 634 | ||||||||||
Earnings per common share: | ||||||||||||||
Net (loss) income applicable to common shareholders per common share - Basic | $ | (1.31) | $ | 2.28 | ||||||||||
Weighted average common shares - Basic | 263.5 | 278.1 | ||||||||||||
Net (loss) income applicable to common shareholders per common share - Diluted | $ | (1.31) | $ | 2.25 | ||||||||||
Weighted average common shares - Diluted | 263.5 | 281.8 | ||||||||||||
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Net (loss) income | $ | (321) | $ | 650 | ||||||||||
Other comprehensive income (loss), after-tax | ||||||||||||||
Changes in: | ||||||||||||||
Unrealized net capital gains and losses | 682 | (1,594) | ||||||||||||
Unrealized foreign currency translation adjustments | 50 | — | ||||||||||||
Unamortized pension and other postretirement prior service credit | (4) | (15) | ||||||||||||
Discount rate for reserve for future policy benefits | (9) | 95 | ||||||||||||
Other comprehensive income (loss), after-tax | 719 | (1,514) | ||||||||||||
Comprehensive income (loss) | 398 | (864) | ||||||||||||
Less: Comprehensive income (loss) attributable to noncontrolling interest | 4 | (22) | ||||||||||||
Comprehensive income (loss) attributable to Allstate | $ | 394 | $ | (842) |
($ in millions, except par value data) | March 31, 2023 | December 31, 2022 | ||||||||||||
Assets | ||||||||||||||
Investments | ||||||||||||||
Fixed income securities, at fair value (amortized cost, net $46,120 and $45,370) | $ | 44,103 | $ | 42,485 | ||||||||||
Equity securities, at fair value (cost $2,147 and $4,253) | 2,174 | 4,567 | ||||||||||||
Mortgage loans, net | 781 | 762 | ||||||||||||
Limited partnership interests | 7,971 | 8,114 | ||||||||||||
Short-term, at fair value (amortized cost $6,722 and $4,174) | 6,722 | 4,173 | ||||||||||||
Other investments, net | 1,724 | 1,728 | ||||||||||||
Total investments | 63,475 | 61,829 | ||||||||||||
Cash | 662 | 736 | ||||||||||||
Premium installment receivables, net | 9,483 | 9,165 | ||||||||||||
Deferred policy acquisition costs | 5,471 | 5,442 | ||||||||||||
Reinsurance and indemnification recoverables, net | 9,528 | 9,619 | ||||||||||||
Accrued investment income | 436 | 423 | ||||||||||||
Deferred income taxes | 345 | 382 | ||||||||||||
Property and equipment, net | 971 | 987 | ||||||||||||
Goodwill | 3,502 | 3,502 | ||||||||||||
Other assets, net | 5,758 | 5,904 | ||||||||||||
Total assets | 99,631 | 97,989 | ||||||||||||
Liabilities | ||||||||||||||
Reserve for property and casualty insurance claims and claims expense | 38,644 | 37,541 | ||||||||||||
Reserve for future policy benefits | 1,338 | 1,322 | ||||||||||||
Contractholder funds | 878 | 879 | ||||||||||||
Unearned premiums | 22,499 | 22,299 | ||||||||||||
Claim payments outstanding | 1,333 | 1,268 | ||||||||||||
Other liabilities and accrued expenses | 9,114 | 9,353 | ||||||||||||
Debt | 8,452 | 7,964 | ||||||||||||
Total liabilities | 82,258 | 80,626 | ||||||||||||
Commitments and Contingent Liabilities (Note 14) | ||||||||||||||
Equity | ||||||||||||||
Preferred stock and additional capital paid-in, $1 par value, 25 million shares authorized, 81.0 thousand shares issued and outstanding, $2,025 aggregate liquidation preference | 1,970 | 1,970 | ||||||||||||
Common stock, $.01 par value, 2.0 billion shares authorized and 900 million issued, 263 million and 263 million shares outstanding | 9 | 9 | ||||||||||||
Additional capital paid-in | 3,780 | 3,788 | ||||||||||||
Retained income | 50,388 | 50,970 | ||||||||||||
Treasury stock, at cost (637 million and 637 million shares) | (36,980) | (36,857) | ||||||||||||
Accumulated other comprehensive income: | ||||||||||||||
Unrealized net capital gains and losses | (1,573) | (2,255) | ||||||||||||
Unrealized foreign currency translation adjustments | (115) | (165) | ||||||||||||
Unamortized pension and other postretirement prior service credit | 25 | 29 | ||||||||||||
Discount rate for reserve for future policy benefits | (10) | (1) | ||||||||||||
Total accumulated other comprehensive income | (1,673) | (2,392) | ||||||||||||
Total Allstate shareholders’ equity | 17,494 | 17,488 | ||||||||||||
Noncontrolling interest | (121) | (125) | ||||||||||||
Total equity | 17,373 | 17,363 | ||||||||||||
Total liabilities and equity | $ | 99,631 | $ | 97,989 |
($ in millions, except per share data) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Preferred stock par value | $ | — | $ | — | ||||||||||
Preferred stock additional capital paid-in | 1,970 | 1,970 | ||||||||||||
Common stock par value | 9 | 9 | ||||||||||||
Common stock additional capital paid-in | ||||||||||||||
Balance, beginning of period | 3,788 | 3,722 | ||||||||||||
Equity incentive plans activity | (8) | (16) | ||||||||||||
Balance, end of period | 3,780 | 3,706 | ||||||||||||
Retained income | ||||||||||||||
Balance, beginning of period | 50,970 | 53,288 | ||||||||||||
Net (loss) income | (320) | 660 | ||||||||||||
Dividends on common stock (declared per share of $0.89 and $0.85) | (236) | (236) | ||||||||||||
Dividends on preferred stock | (26) | (26) | ||||||||||||
Balance, end of period | 50,388 | 53,686 | ||||||||||||
Treasury stock | ||||||||||||||
Balance, beginning of period | (36,857) | (34,471) | ||||||||||||
Shares acquired | (153) | (794) | ||||||||||||
Shares reissued under equity incentive plans, net | 30 | 57 | ||||||||||||
Balance, end of period | (36,980) | (35,208) | ||||||||||||
Accumulated other comprehensive income | ||||||||||||||
Balance, beginning of period | (2,392) | 426 | ||||||||||||
Change in unrealized net capital gains and losses | 682 | (1,594) | ||||||||||||
Change in unrealized foreign currency translation adjustments | 50 | — | ||||||||||||
Change in unamortized pension and other postretirement prior service credit | (4) | (15) | ||||||||||||
Change in discount rate for reserve for future policy benefits | (9) | 95 | ||||||||||||
Balance, end of period | (1,673) | (1,088) | ||||||||||||
Total Allstate shareholders’ equity | 17,494 | 23,075 | ||||||||||||
Noncontrolling interest | ||||||||||||||
Balance, beginning of period | (125) | (52) | ||||||||||||
Change in unrealized net capital gains and losses | 5 | (12) | ||||||||||||
Noncontrolling loss | (1) | (10) | ||||||||||||
Balance, end of period | (121) | (74) | ||||||||||||
Total equity | $ | 17,373 | $ | 23,001 |
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Cash flows from operating activities | ||||||||||||||
Net (loss) income | $ | (321) | $ | 650 | ||||||||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||||||||
Depreciation, amortization and other non-cash items | 177 | 236 | ||||||||||||
Net (gains) losses on investments and derivatives | (14) | 267 | ||||||||||||
Pension and other postretirement remeasurement (gains) losses | (53) | (247) | ||||||||||||
Changes in: | ||||||||||||||
Policy benefits and other insurance reserves | 1,080 | (111) | ||||||||||||
Unearned premiums | 199 | 390 | ||||||||||||
Deferred policy acquisition costs | (29) | (103) | ||||||||||||
Premium installment receivables, net | (317) | (502) | ||||||||||||
Reinsurance recoverables, net | 91 | 333 | ||||||||||||
Income taxes | (125) | 93 | ||||||||||||
Other operating assets and liabilities | (87) | (574) | ||||||||||||
Net cash provided by operating activities | 601 | 432 | ||||||||||||
Cash flows from investing activities | ||||||||||||||
Proceeds from sales | ||||||||||||||
Fixed income securities | 7,008 | 12,400 | ||||||||||||
Equity securities | 3,739 | 5,216 | ||||||||||||
Limited partnership interests | 414 | 300 | ||||||||||||
Other investments | 55 | 208 | ||||||||||||
Investment collections | ||||||||||||||
Fixed income securities | 646 | 104 | ||||||||||||
Mortgage loans | 22 | 3 | ||||||||||||
Other investments | 25 | 49 | ||||||||||||
Investment purchases | ||||||||||||||
Fixed income securities | (8,424) | (13,220) | ||||||||||||
Equity securities | (1,187) | (3,624) | ||||||||||||
Limited partnership interests | (226) | (216) | ||||||||||||
Mortgage loans | (41) | (37) | ||||||||||||
Other investments | (73) | (186) | ||||||||||||
Change in short-term and other investments, net | (2,675) | 114 | ||||||||||||
Purchases of property and equipment, net | (79) | (130) | ||||||||||||
Net cash (used in) provided by investing activities | (796) | 981 | ||||||||||||
Cash flows from financing activities | ||||||||||||||
Proceeds from issuance of long-term debt | 744 | — | ||||||||||||
Redemption and repayment of debt | (250) | — | ||||||||||||
Contractholder fund deposits | 33 | 34 | ||||||||||||
Contractholder fund withdrawals | (9) | (9) | ||||||||||||
Dividends paid on common stock | (224) | (230) | ||||||||||||
Dividends paid on preferred stock | (26) | (26) | ||||||||||||
Treasury stock purchases | (153) | (802) | ||||||||||||
Shares reissued under equity incentive plans, net | 6 | 17 | ||||||||||||
Other | — | (30) | ||||||||||||
Net cash provided by (used in) financing activities | 121 | (1,046) | ||||||||||||
Net (decrease) increase in cash | (74) | 367 | ||||||||||||
Cash at beginning of period | 736 | 763 | ||||||||||||
Cash at end of period | $ | 662 | $ | 1,130 |
Note 1 | General |
After-tax cumulative effect of change in accounting principle on transition date | ||||||||
($ in millions) | January 1, 2021 | |||||||
Decrease in retained income | $ | 21 | ||||||
Decrease in accumulated other comprehensive income (“AOCI”) | 277 | |||||||
Total decrease in equity | $ | 298 |
Impact of adoption for reserve for future policy benefits | ||||||||||||||||||||
( $ in millions) | Accident and health | Traditional life | Total | |||||||||||||||||
Pre-adoption 12/31/2020 balance (1) | $ | 728 | $ | 311 | $ | 1,039 | ||||||||||||||
Adjustments: | ||||||||||||||||||||
Effect of the remeasurement of the reserve at upper-medium grade fixed income-based rate (2) | 232 | 153 | 385 | |||||||||||||||||
Adjustments for contracts with net premiums in excess of gross premiums (3) | 77 | — | 77 | |||||||||||||||||
Total adjustments | 309 | 153 | 462 | |||||||||||||||||
Post-adoption 1/1/2021 balance | 1,037 | 464 | 1,501 | |||||||||||||||||
Less: reinsurance recoverables (4) | 159 | 3 | 162 | |||||||||||||||||
Post-adoption 1/1/2021 balance, after reinsurance recoverables | $ | 878 | $ | 461 | $ | 1,339 |
Impact of adoption for DAC | ||||||||||||||||||||||||||
( $ in millions) | Accident and health | Traditional life | Interest- sensitive life | Total | ||||||||||||||||||||||
Pre-adoption 12/31/2020 balance | $ | 343 | $ | 32 | $ | 95 | $ | 470 | ||||||||||||||||||
Adjustment for removal of impact of unrealized gains or losses (1) | — | — | 2 | 2 | ||||||||||||||||||||||
Post-adoption 1/1/2021 balance | $ | 343 | $ | 32 | $ | 97 | $ | 472 |
Consolidated Statements of Operations | ||||||||||||||||||||
Three months ended March 31, 2022 | ||||||||||||||||||||
($ in millions, except per share data) | As reported | Impact of change | As adjusted | |||||||||||||||||
Revenues | ||||||||||||||||||||
Accident and health insurance premiums and contract charges | $ | 469 | $ | (1) | $ | 468 | ||||||||||||||
Total revenues | 12,337 | (1) | 12,336 | |||||||||||||||||
Costs and expenses | ||||||||||||||||||||
Accident, health and other policy benefits | 269 | (1) | 268 | |||||||||||||||||
Amortization of deferred policy acquisition costs | 1,612 | (4) | 1,608 | |||||||||||||||||
Total costs and expenses | 11,540 | (5) | 11,535 | |||||||||||||||||
Income from operations before income tax expense | 797 | 4 | 801 | |||||||||||||||||
Income tax expense | 151 | — | 151 | |||||||||||||||||
Net income | 646 | 4 | 650 | |||||||||||||||||
Net income attributable to Allstate | 656 | 4 | 660 | |||||||||||||||||
Net income applicable to common shareholders | $ | 630 | $ | 4 | $ | 634 | ||||||||||||||
Earnings per common share: | ||||||||||||||||||||
Net income applicable to common shareholders per common share - Basic | $ | 2.27 | $ | 0.01 | $ | 2.28 | ||||||||||||||
Net income applicable to common shareholders per common share - Diluted | $ | 2.24 | $ | 0.01 | $ | 2.25 |
Condensed Consolidated Statements of Comprehensive Income (unaudited) | ||||||||||||||||||||
Three months ended March 31, 2022 | ||||||||||||||||||||
($ in millions) | As reported | Impact of change | As adjusted | |||||||||||||||||
Net income | $ | 646 | $ | 4 | $ | 650 | ||||||||||||||
Other comprehensive income (loss), after-tax | ||||||||||||||||||||
Changes in: | ||||||||||||||||||||
Unrealized net capital gains and losses | (1,593) | (1) | (1,594) | |||||||||||||||||
Discount rate for reserve for future policy benefits | — | 95 | 95 | |||||||||||||||||
Other comprehensive loss, after-tax | (1,608) | 94 | (1,514) | |||||||||||||||||
Comprehensive loss | (962) | 98 | (864) | |||||||||||||||||
Comprehensive loss attributable to Allstate | $ | (940) | $ | 98 | $ | (842) | ||||||||||||||
Condensed Consolidated Statements of Shareholders’ Equity (unaudited) | ||||||||||||||||||||
Three months ended March 31, 2022 | ||||||||||||||||||||
($ in millions) | As reported | Impact of change | As adjusted | |||||||||||||||||
Retained income | ||||||||||||||||||||
Balance, beginning of period | $ | 53,294 | $ | (6) | $ | 53,288 | ||||||||||||||
Net income | 656 | 4 | 660 | |||||||||||||||||
Balance, end of period | 53,688 | (2) | 53,686 | |||||||||||||||||
Accumulated other comprehensive income (loss) | ||||||||||||||||||||
Balance, beginning of period | 655 | (229) | 426 | |||||||||||||||||
Change in unrealized net capital gains and losses | (1,593) | (1) | (1,594) | |||||||||||||||||
Change in discount rate for reserve for future policy benefits | — | 95 | 95 | |||||||||||||||||
Balance, end of period | (953) | (135) | (1,088) | |||||||||||||||||
Total Allstate shareholders’ equity | 23,212 | (137) | 23,075 | |||||||||||||||||
Total equity | $ | 23,138 | $ | (137) | $ | 23,001 |
Note 2 | Earnings per Common Share |
Computation of basic and diluted earnings per common share | ||||||||||||||
(In millions, except per share data) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Numerator: | ||||||||||||||
Net (loss) income | $ | (321) | $ | 650 | ||||||||||
Less: Net loss attributable to noncontrolling interest | (1) | (10) | ||||||||||||
Net (loss) income attributable to Allstate | (320) | 660 | ||||||||||||
Less: Preferred stock dividends | 26 | 26 | ||||||||||||
Net (loss) income applicable to common shareholders | $ | (346) | $ | 634 | ||||||||||
Denominator: | ||||||||||||||
Weighted average common shares outstanding | 263.5 | 278.1 | ||||||||||||
Effect of dilutive potential common shares (1): | ||||||||||||||
Stock options | — | 2.6 | ||||||||||||
Restricted stock units (non-participating) and performance stock awards | — | 1.1 | ||||||||||||
Weighted average common and dilutive potential common shares outstanding | 263.5 | 281.8 | ||||||||||||
Earnings per common share - Basic | $ | (1.31) | $ | 2.28 | ||||||||||
Earnings per common share - Diluted (1) | $ | (1.31) | $ | 2.25 | ||||||||||
Anti-dilutive options excluded from diluted earnings per common share | 1.1 | 1.2 | ||||||||||||
Weighted average dilutive potential common shares excluded due to net loss applicable to common shareholders (1) | 2.6 | — |
Note 3 | Reportable Segments |
• | Net gains and losses on investments and derivatives | ||||
• | Pension and other postretirement remeasurement gains and losses | ||||
• | Amortization or impairment of purchased intangibles | ||||
• | Gain or loss on disposition | ||||
• | Adjustments for other significant non-recurring, infrequent or unusual items, when (a) the nature of the charge or gain is such that it is reasonably unlikely to recur within two years, or (b) there has been no similar charge or gain within the prior two years | ||||
• | Income tax expense or benefit on reconciling items |
Reportable segments financial performance | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Underwriting income (loss) by segment | ||||||||||||||
Allstate Protection | $ | (998) | $ | 282 | ||||||||||
Run-off Property-Liability | (3) | (2) | ||||||||||||
Total Property-Liability | (1,001) | 280 | ||||||||||||
Adjusted net income (loss) by segment, after-tax | ||||||||||||||
Protection Services | 34 | 53 | ||||||||||||
Allstate Health and Benefits | 56 | 57 | ||||||||||||
Corporate and Other | (89) | (111) | ||||||||||||
Reconciling items | ||||||||||||||
Property-Liability net investment income | 509 | 558 | ||||||||||||
Net gains (losses) on investments and derivatives | 14 | (267) | ||||||||||||
Pension and other postretirement remeasurement gains (losses) | 53 | 247 | ||||||||||||
Amortization of purchased intangibles (1) | (24) | (29) | ||||||||||||
Gain (loss) on disposition | 9 | (16) | ||||||||||||
Income tax benefit (expense) on reconciling items | 92 | (148) | ||||||||||||
Total reconciling items | 653 | 345 | ||||||||||||
Less: Net loss attributable to noncontrolling interest (2) | (1) | (10) | ||||||||||||
Net (loss) income applicable to common shareholders | $ | (346) | $ | 634 |
Reportable segments revenue information | ||||||||||||||
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Property-Liability | ||||||||||||||
Insurance premiums | ||||||||||||||
Auto | $ | 7,908 | $ | 7,081 | ||||||||||
Homeowners | 2,810 | 2,490 | ||||||||||||
Other personal lines | 562 | 531 | ||||||||||||
Commercial lines | 232 | 283 | ||||||||||||
Other business lines | 123 | 113 | ||||||||||||
Allstate Protection | 11,635 | 10,498 | ||||||||||||
Run-off Property-Liability | — | — | ||||||||||||
Total Property-Liability insurance premiums | 11,635 | 10,498 | ||||||||||||
Other revenue | 353 | 347 | ||||||||||||
Net investment income | 509 | 558 | ||||||||||||
Net gains (losses) on investments and derivatives | 12 | (203) | ||||||||||||
Total Property-Liability | 12,509 | 11,200 | ||||||||||||
Protection Services | ||||||||||||||
Protection plans | 361 | 313 | ||||||||||||
Roadside assistance | 49 | 53 | ||||||||||||
Finance and insurance products | 128 | 117 | ||||||||||||
Intersegment premiums and service fees (1) | 33 | 41 | ||||||||||||
Other revenue | 84 | 94 | ||||||||||||
Net investment income | 16 | 9 | ||||||||||||
Net gains (losses) on investments and derivatives | (1) | (13) | ||||||||||||
Total Protection Services | 670 | 614 | ||||||||||||
Allstate Health and Benefits | ||||||||||||||
Employer voluntary benefits | 255 | 263 | ||||||||||||
Group health | 107 | 94 | ||||||||||||
Individual health | 101 | 111 | ||||||||||||
Other revenue | 101 | 95 | ||||||||||||
Net investment income | 19 | 17 | ||||||||||||
Net gains (losses) on investments and derivatives | 2 | (7) | ||||||||||||
Total Allstate Health and Benefits | 585 | 573 | ||||||||||||
Corporate and Other | ||||||||||||||
Other revenue | 23 | 24 | ||||||||||||
Net investment income | 31 | 10 | ||||||||||||
Net gains (losses) on investments and derivatives | 1 | (44) | ||||||||||||
Total Corporate and Other | 55 | (10) | ||||||||||||
Intersegment eliminations (1) | (33) | (41) | ||||||||||||
Consolidated revenues | $ | 13,786 | $ | 12,336 |
Note 4 | Investments |
Portfolio composition | ||||||||||||||
($ in millions) | March 31, 2023 | December 31, 2022 | ||||||||||||
Fixed income securities, at fair value | $ | 44,103 | $ | 42,485 | ||||||||||
Equity securities, at fair value | 2,174 | 4,567 | ||||||||||||
Mortgage loans, net | 781 | 762 | ||||||||||||
Limited partnership interests | 7,971 | 8,114 | ||||||||||||
Short-term investments, at fair value | 6,722 | 4,173 | ||||||||||||
Other investments, net | 1,724 | 1,728 | ||||||||||||
Total | $ | 63,475 | $ | 61,829 |
Net investment income | ||||||||||||||
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Fixed income securities | $ | 390 | $ | 267 | ||||||||||
Equity securities | 11 | 36 | ||||||||||||
Mortgage loans | 8 | 8 | ||||||||||||
Limited partnership interests | 134 | 292 | ||||||||||||
Short-term investments | 66 | 2 | ||||||||||||
Other investments | 41 | 40 | ||||||||||||
Investment income, before expense | 650 | 645 | ||||||||||||
Investment expense | (75) | (51) | ||||||||||||
Net investment income | $ | 575 | $ | 594 |
Net gains (losses) on investments and derivatives by asset type | ||||||||||||||
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Fixed income securities | $ | (136) | $ | (152) | ||||||||||
Equity securities | 167 | (347) | ||||||||||||
Mortgage loans | — | (1) | ||||||||||||
Limited partnership interests | 22 | (101) | ||||||||||||
Derivatives | (52) | 318 | ||||||||||||
Other investments | 13 | 16 | ||||||||||||
Net gains (losses) on investments and derivatives | $ | 14 | $ | (267) |
Net gains (losses) on investments and derivatives by transaction type | ||||||||||||||
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Sales | $ | (120) | $ | (127) | ||||||||||
Credit losses | (12) | (11) | ||||||||||||
Valuation change of equity investments (1) | 198 | (447) | ||||||||||||
Valuation change and settlements of derivatives | (52) | 318 | ||||||||||||
Net gains (losses) on investments and derivatives | $ | 14 | $ | (267) |
Gross realized gains (losses) on sales of fixed income securities | ||||||||||||||
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Gross realized gains | $ | 46 | $ | 66 | ||||||||||
Gross realized losses | (173) | (218) |
Net appreciation (decline) recognized in net income for assets that are still held | ||||||||||||||
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Equity securities | $ | 20 | $ | (92) | ||||||||||
Limited partnership interests carried at fair value | 16 | 38 | ||||||||||||
Total | $ | 36 | $ | (54) |
Credit losses recognized in net income | ||||||||||||||
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Assets | ||||||||||||||
Fixed income securities: | ||||||||||||||
Corporate | $ | (9) | $ | — | ||||||||||
Total fixed income securities | (9) | — | ||||||||||||
Mortgage loans | — | (1) | ||||||||||||
Other investments | ||||||||||||||
Bank loans | (3) | (10) | ||||||||||||
Total credit losses by asset type | $ | (12) | $ | (11) | ||||||||||
Liabilities | ||||||||||||||
Commitments to fund commercial mortgage loans and bank loans | — | — | ||||||||||||
Total | $ | (12) | $ | (11) |
Unrealized net capital gains and losses included in AOCI | ||||||||||||||||||||||||||
($ in millions) | Fair value | Gross unrealized | Unrealized net gains (losses) | |||||||||||||||||||||||
March 31, 2023 | Gains | Losses | ||||||||||||||||||||||||
Fixed income securities | $ | 44,103 | $ | 211 | $ | (2,228) | $ | (2,017) | ||||||||||||||||||
Short-term investments | 6,722 | — | — | — | ||||||||||||||||||||||
Derivative instruments | — | — | (2) | (2) | ||||||||||||||||||||||
Limited partnership interests (1) | 4 | |||||||||||||||||||||||||
Unrealized net capital gains and losses, pre-tax | (2,015) | |||||||||||||||||||||||||
Other unrealized net capital gains and losses, pre-tax (2) | 18 | |||||||||||||||||||||||||
Deferred income taxes | 424 | |||||||||||||||||||||||||
Unrealized net capital gains and losses, after-tax | $ | (1,573) | ||||||||||||||||||||||||
December 31, 2022 | ||||||||||||||||||||||||||
Fixed income securities | $ | 42,485 | $ | 92 | $ | (2,977) | $ | (2,885) | ||||||||||||||||||
Short-term investments | 4,173 | — | (1) | (1) | ||||||||||||||||||||||
Derivative instruments | — | — | (3) | (3) | ||||||||||||||||||||||
Limited partnership interests (1) | 2 | |||||||||||||||||||||||||
Unrealized net capital gains and losses, pre-tax | (2,887) | |||||||||||||||||||||||||
Other unrealized net capital gains and losses, pre-tax (2) | 23 | |||||||||||||||||||||||||
Deferred income taxes | 609 | |||||||||||||||||||||||||
Unrealized net capital gains and losses, after-tax | $ | (2,255) |
Change in unrealized net capital gains (losses) | ||||||||
($ in millions) | Three months ended March 31, 2023 | |||||||
Fixed income securities | $ | 868 | ||||||
Short-term investments | 1 | |||||||
Derivative instruments | 1 | |||||||
Limited partnership interests | 2 | |||||||
Total | 872 | |||||||
Other unrealized net capital gains and losses, pre-tax | (5) | |||||||
Deferred income taxes | (185) | |||||||
Increase in unrealized net capital gains and losses, after-tax | $ | 682 |
Carrying value for limited partnership interests | ||||||||||||||||||||||||||||||||||||||
($ in millions) | March 31, 2023 | December 31, 2022 | ||||||||||||||||||||||||||||||||||||
EMA | Fair Value | Total | EMA | Fair Value | Total | |||||||||||||||||||||||||||||||||
Private equity | $ | 5,546 | $ | 1,199 | $ | 6,745 | $ | 5,372 | $ | 1,217 | $ | 6,589 | ||||||||||||||||||||||||||
Real estate | 1,019 | 29 | 1,048 | 1,013 | 29 | 1,042 | ||||||||||||||||||||||||||||||||
Other (1) | 178 | — | 178 | 483 | — | 483 | ||||||||||||||||||||||||||||||||
Total | $ | 6,743 | $ | 1,228 | $ | 7,971 | $ | 6,868 | $ | 1,246 | $ | 8,114 |
Other investments by asset type | ||||||||||||||
($ in millions) | March 31, 2023 | December 31, 2022 | ||||||||||||
Bank loans, net | $ | 698 | $ | 686 | ||||||||||
Real estate | 790 | 813 | ||||||||||||
Policy loans | 120 | 120 | ||||||||||||
Derivatives | 10 | 1 | ||||||||||||
Other | 106 | 108 | ||||||||||||
Total | $ | 1,724 | $ | 1,728 |
Rollforward of credit loss allowance for fixed income securities | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Beginning balance | $ | (13) | $ | (6) | ||||||||||
Credit losses on securities for which credit losses not previously reported | — | — | ||||||||||||
Net increases related to credit losses previously reported | (9) | — | ||||||||||||
Reduction of allowance related to sales | — | — | ||||||||||||
Write-offs | — | — | ||||||||||||
Ending balance | $ | (22) | $ | (6) | ||||||||||
Components of credit loss allowance | ||||||||||||||
Corporate bonds | $ | (20) | $ | (6) | ||||||||||
ABS | (2) | — | ||||||||||||
Total | $ | (22) | $ | (6) |
Gross unrealized losses and fair value by type and length of time held in a continuous unrealized loss position | ||||||||||||||||||||||||||||||||||||||||||||
($ in millions) | Less than 12 months | 12 months or more | Total unrealized losses | |||||||||||||||||||||||||||||||||||||||||
Number of issues | Fair value | Unrealized losses | Number of issues | Fair value | Unrealized losses | |||||||||||||||||||||||||||||||||||||||
March 31, 2023 | ||||||||||||||||||||||||||||||||||||||||||||
Fixed income securities | ||||||||||||||||||||||||||||||||||||||||||||
U.S. government and agencies | 70 | $ | 2,576 | $ | (41) | 104 | $ | 3,216 | $ | (111) | $ | (152) | ||||||||||||||||||||||||||||||||
Municipal | 1,183 | 1,632 | (27) | 1,860 | 2,376 | (213) | (240) | |||||||||||||||||||||||||||||||||||||
Corporate | 970 | 8,673 | (286) | 1,777 | 14,543 | (1,501) | (1,787) | |||||||||||||||||||||||||||||||||||||
Foreign government | 15 | 197 | (1) | 87 | 452 | (23) | (24) | |||||||||||||||||||||||||||||||||||||
ABS | 74 | 160 | (5) | 152 | 669 | (20) | (25) | |||||||||||||||||||||||||||||||||||||
Total fixed income securities | 2,312 | $ | 13,238 | $ | (360) | 3,980 | $ | 21,256 | $ | (1,868) | $ | (2,228) | ||||||||||||||||||||||||||||||||
Investment grade fixed income securities | 2,132 | $ | 12,415 | $ | (313) | 3,601 | $ | 18,633 | $ | (1,509) | $ | (1,822) | ||||||||||||||||||||||||||||||||
Below investment grade fixed income securities | 180 | 823 | (47) | 379 | 2,623 | (359) | (406) | |||||||||||||||||||||||||||||||||||||
Total fixed income securities | 2,312 | $ | 13,238 | $ | (360) | 3,980 | $ | 21,256 | $ | (1,868) | $ | (2,228) | ||||||||||||||||||||||||||||||||
December 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||
Fixed income securities | ||||||||||||||||||||||||||||||||||||||||||||
U.S. government and agencies | 112 | $ | 4,900 | $ | (138) | 75 | $ | 2,393 | $ | (93) | $ | (231) | ||||||||||||||||||||||||||||||||
Municipal | 3,015 | 3,944 | (215) | 507 | 740 | (111) | (326) | |||||||||||||||||||||||||||||||||||||
Corporate | 2,085 | 18,072 | (1,389) | 845 | 6,105 | (956) | (2,345) | |||||||||||||||||||||||||||||||||||||
Foreign government | 74 | 739 | (22) | 42 | 200 | (18) | (40) | |||||||||||||||||||||||||||||||||||||
ABS | 194 | 874 | (27) | 83 | 109 | (8) | (35) | |||||||||||||||||||||||||||||||||||||
Total fixed income securities | 5,480 | $ | 28,529 | $ | (1,791) | 1,552 | $ | 9,547 | $ | (1,186) | $ | (2,977) | ||||||||||||||||||||||||||||||||
Investment grade fixed income securities | 4,959 | $ | 25,487 | $ | (1,409) | 1,437 | $ | 8,791 | $ | (1,009) | $ | (2,418) | ||||||||||||||||||||||||||||||||
Below investment grade fixed income securities | 521 | 3,042 | (382) | 115 | 756 | (177) | (559) | |||||||||||||||||||||||||||||||||||||
Total fixed income securities | 5,480 | $ | 28,529 | $ | (1,791) | 1,552 | $ | 9,547 | $ | (1,186) | $ | (2,977) |
Gross unrealized losses by unrealized loss position and credit quality as of March 31, 2023 | ||||||||||||||||||||
($ in millions) | Investment grade | Below investment grade | Total | |||||||||||||||||
Fixed income securities with unrealized loss position less than 20% of amortized cost, net (1) (2) | $ | (1,669) | $ | (296) | $ | (1,965) | ||||||||||||||
Fixed income securities with unrealized loss position greater than or equal to 20% of amortized cost, net (3) (4) | (153) | (110) | (263) | |||||||||||||||||
Total unrealized losses | $ | (1,822) | $ | (406) | $ | (2,228) |
Accrued interest | ||||||||||||||
($ in millions) | March 31, | December 31, | ||||||||||||
2023 | 2022 | |||||||||||||
Mortgage loans | $ | 3 | $ | 3 | ||||||||||
Bank Loans | 4 | 3 |
Rollforward of credit loss allowance for mortgage loans | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Beginning balance | $ | (7) | $ | (6) | ||||||||||
Net increases related to credit losses | — | (1) | ||||||||||||
Write-offs | — | — | ||||||||||||
Ending balance | $ | (7) | $ | (7) | ||||||||||
Bank loans amortized cost by credit rating and year of origination | ||||||||||||||||||||||||||||||||||||||||||||||||||
March 31, 2023 | December 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||
($ in millions) | 2018 and prior | 2019 | 2020 | 2021 | 2022 | Current | Total | Total | ||||||||||||||||||||||||||||||||||||||||||
NAIC 2 / BBB | $ | — | $ | 7 | $ | 5 | $ | 45 | $ | 4 | $ | — | $ | 61 | $ | 54 | ||||||||||||||||||||||||||||||||||
NAIC 3 / BB | 5 | 4 | 3 | 202 | 16 | 22 | 252 | 266 | ||||||||||||||||||||||||||||||||||||||||||
NAIC 4 / B | 22 | 17 | 15 | 223 | 38 | 32 | 347 | 329 | ||||||||||||||||||||||||||||||||||||||||||
NAIC 5-6/ CCC and below | 31 | 34 | 1 | 16 | 6 | 2 | 90 | 94 | ||||||||||||||||||||||||||||||||||||||||||
Amortized cost before allowance | $ | 58 | $ | 62 | $ | 24 | $ | 486 | $ | 64 | $ | 56 | $ | 750 | $ | 743 | ||||||||||||||||||||||||||||||||||
Allowance | (52) | (57) | ||||||||||||||||||||||||||||||||||||||||||||||||
Amortized cost, net | $ | 698 | $ | 686 | ||||||||||||||||||||||||||||||||||||||||||||||
Rollforward of credit loss allowance for bank loans | ||||||||||||||
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Beginning balance | $ | (57) | $ | (61) | ||||||||||
Net increases related to credit losses | (3) | (10) | ||||||||||||
Reduction of allowance related to sales | 5 | 3 | ||||||||||||
Write-offs | 3 | — | ||||||||||||
Ending balance | $ | (52) | $ | (68) |
Note 5 | Fair Value of Assets and Liabilities |
Assets and liabilities measured at fair value | ||||||||||||||||||||||||||||||||
March 31, 2023 | ||||||||||||||||||||||||||||||||
($ in millions) | Quoted prices in active markets for identical assets (Level 1) | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | Counterparty and cash collateral netting | Total | |||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||||||||||||||
U.S. government and agencies | $ | 7,678 | $ | 17 | $ | — | $ | 7,695 | ||||||||||||||||||||||||
Municipal | — | 6,307 | 17 | 6,324 | ||||||||||||||||||||||||||||
Corporate - public | — | 20,320 | 29 | 20,349 | ||||||||||||||||||||||||||||
Corporate - privately placed | — | 7,638 | 49 | 7,687 | ||||||||||||||||||||||||||||
Foreign government | — | 1,091 | — | 1,091 | ||||||||||||||||||||||||||||
ABS | — | 930 | 27 | 957 | ||||||||||||||||||||||||||||
Total fixed income securities | 7,678 | 36,303 | 122 | 44,103 | ||||||||||||||||||||||||||||
Equity securities | 1,523 | 293 | 358 | 2,174 | ||||||||||||||||||||||||||||
Short-term investments | 2,034 | 4,682 | 6 | 6,722 | ||||||||||||||||||||||||||||
Other investments | — | 10 | 2 | $ | — | 12 | ||||||||||||||||||||||||||
Other assets | 4 | — | 112 | 116 | ||||||||||||||||||||||||||||
Total recurring basis assets | 11,239 | 41,288 | 600 | — | 53,127 | |||||||||||||||||||||||||||
Non-recurring basis | — | — | 19 | 19 | ||||||||||||||||||||||||||||
Total assets at fair value | $ | 11,239 | $ | 41,288 | $ | 619 | $ | — | $ | 53,146 | ||||||||||||||||||||||
% of total assets at fair value | 21.1 | % | 77.7 | % | 1.2 | % | — | % | 100.0 | % | ||||||||||||||||||||||
Investments reported at NAV | 1,228 | |||||||||||||||||||||||||||||||
Total | $ | 54,374 | ||||||||||||||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||||||||
Other liabilities | $ | (5) | $ | (16) | $ | — | $ | 16 | $ | (5) | ||||||||||||||||||||||
Total recurring basis liabilities | (5) | (16) | — | 16 | (5) | |||||||||||||||||||||||||||
Total liabilities at fair value | $ | (5) | $ | (16) | $ | — | $ | 16 | $ | (5) | ||||||||||||||||||||||
% of total liabilities at fair value | 100.0 | % | 320.0 | % | — | % | (320.0) | % | 100.0 | % |
Rollforward of Level 3 assets and liabilities held at fair value during the three month period ended March 31, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2022 | Total gains (losses) included in: | Transfers | Balance as of March 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
($ in millions) | Net income | OCI | Into Level 3 | Out of Level 3 | Purchases | Sales | Issues | Settlements | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Municipal | $ | 21 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | (3) | $ | — | $ | (1) | $ | 17 | ||||||||||||||||||||||||||||||||||||||||||
Corporate - public | 69 | (1) | 2 | — | — | — | (41) | — | — | 29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate - privately placed | 55 | (4) | — | — | — | — | (2) | — | — | 49 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
ABS | 28 | — | — | — | — | — | — | — | (1) | 27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Total fixed income securities | 173 | (5) | 2 | — | — | — | (46) | — | (2) | 122 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity securities | 333 | — | — | — | — | 42 | (17) | — | — | 358 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Short-term investments | 6 | — | — | — | — | — | — | — | — | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Other investments | 3 | (1) | — | — | — | — | — | — | — | 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Other assets | 103 | 9 | — | — | — | — | — | — | — | 112 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Total recurring Level 3 assets | $ | 618 | $ | 3 | $ | 2 | $ | — | $ | — | $ | 42 | $ | (63) | $ | — | $ | (2) | $ | 600 | ||||||||||||||||||||||||||||||||||||||||||
Total Level 3 gains (losses) included in net income | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
$ | (5) | $ | 9 | |||||||||||
8 | 29 |
Financial instruments not carried at fair value | ||||||||||||||||||||||||||||||||
($ in millions) | March 31, 2023 | December 31, 2022 | ||||||||||||||||||||||||||||||
Financial assets | Fair value level | Amortized cost, net | Fair value | Amortized cost, net | Fair value | |||||||||||||||||||||||||||
Mortgage loans | Level 3 | $ | 781 | $ | 724 | $ | 762 | $ | 700 | |||||||||||||||||||||||
Bank loans | Level 3 | 698 | 706 | 686 | 686 | |||||||||||||||||||||||||||
Financial liabilities | Fair value level | Carrying value (1) | Fair value | Carrying value (1) | Fair value | |||||||||||||||||||||||||||
Contractholder funds on investment contracts | Level 3 | $ | 48 | $ | 48 | $ | 50 | $ | 50 | |||||||||||||||||||||||
Debt | Level 2 | 8,452 | 8,089 | 7,964 | 7,449 | |||||||||||||||||||||||||||
Liability for collateral | Level 2 | 1,807 | 1,807 | 2,011 | 2,011 | |||||||||||||||||||||||||||
Note 6 | Derivative Financial Instruments |
Summary of the volume and fair value positions of derivative instruments as of December 31, 2022 | |||||||||||||||||||||||||||||||||||
($ in millions, except number of contracts) | Volume (1) | ||||||||||||||||||||||||||||||||||
Balance sheet location | Notional amount | Number of contracts | Fair value, net | Gross asset | Gross liability | ||||||||||||||||||||||||||||||
Asset derivatives | |||||||||||||||||||||||||||||||||||
Derivatives not designated as accounting hedging instruments | |||||||||||||||||||||||||||||||||||
Interest rate contracts | |||||||||||||||||||||||||||||||||||
Futures | Other assets | n/a | 24,380 | $ | 3 | $ | 3 | $ | — | ||||||||||||||||||||||||||
Equity and index contracts | |||||||||||||||||||||||||||||||||||
Futures | Other assets | n/a | 343 | — | — | — | |||||||||||||||||||||||||||||
Foreign currency contracts | |||||||||||||||||||||||||||||||||||
Foreign currency forwards | Other investments | $ | 354 | n/a | 1 | 14 | (13) | ||||||||||||||||||||||||||||
Contingent consideration | Other assets | 250 | n/a | 103 | 103 | — | |||||||||||||||||||||||||||||
Credit default contracts | |||||||||||||||||||||||||||||||||||
Credit default swaps – buying protection | Other investments | 24 | n/a | — | 1 | (1) | |||||||||||||||||||||||||||||
Total asset derivatives | $ | 628 | 24,723 | $ | 107 | $ | 121 | $ | (14) | ||||||||||||||||||||||||||
Liability derivatives | |||||||||||||||||||||||||||||||||||
Derivatives not designated as accounting hedging instruments | |||||||||||||||||||||||||||||||||||
Interest rate contracts | |||||||||||||||||||||||||||||||||||
Futures | Other liabilities & accrued expenses | n/a | 1,624 | $ | — | $ | — | $ | — | ||||||||||||||||||||||||||
Equity and index contracts | |||||||||||||||||||||||||||||||||||
Futures | Other liabilities & accrued expenses | n/a | 1,229 | (1) | — | (1) | |||||||||||||||||||||||||||||
Foreign currency contracts | |||||||||||||||||||||||||||||||||||
Foreign currency forwards | Other liabilities & accrued expenses | $ | 283 | n/a | — | 7 | (7) | ||||||||||||||||||||||||||||
Credit default contracts | |||||||||||||||||||||||||||||||||||
Credit default swaps – buying protection | Other liabilities & accrued expenses | 525 | n/a | (3) | 1 | (4) | |||||||||||||||||||||||||||||
Total liability derivatives | 808 | 2,853 | (4) | $ | 8 | $ | (12) | ||||||||||||||||||||||||||||
Total derivatives | $ | 1,436 | 27,576 | $ | 103 |
OTC cash and securities collateral pledged | ||||||||
($ in millions) | March 31, 2023 | |||||||
Pledged by the Company | $ | 19 | ||||||
Pledged to the Company (1) | 3 |
Exchange traded and cleared margin deposits | ||||||||
($ in millions) | March 31, 2023 | |||||||
Pledged by the Company | $ | 146 | ||||||
Received by the Company | — |
($ in millions) | March 31, 2023 | December 31, 2022 | ||||||||||||
Gross liability fair value of contracts containing credit-risk-contingent features | $ | 4 | $ | 21 | ||||||||||
Gross asset fair value of contracts containing credit-risk-contingent features and subject to MNAs | (3) | (11) | ||||||||||||
Collateral posted under MNAs for contracts containing credit-risk-contingent features | (1) | (10) | ||||||||||||
Maximum amount of additional exposure for contracts with credit-risk-contingent features if all features were triggered concurrently | $ | — | $ | — |
Note 7 | Variable Interest Entities |
Assets and liabilities of Reciprocal Exchanges | ||||||||||||||
($ in millions) | March 31, 2023 | December 31, 2022 | ||||||||||||
Assets | ||||||||||||||
Fixed income securities | $ | 285 | $ | 302 | ||||||||||
Short-term investments | 16 | 13 | ||||||||||||
Deferred policy acquisition costs | 23 | 15 | ||||||||||||
Premium installment and other receivables, net | 36 | 43 | ||||||||||||
Reinsurance recoverables, net | 88 | 97 | ||||||||||||
Other assets | 37 | 90 | ||||||||||||
Total assets | 485 | 560 | ||||||||||||
Liabilities | ||||||||||||||
Reserve for property and casualty insurance claims and claims expense | 194 | 209 | ||||||||||||
Unearned premiums | 132 | 171 | ||||||||||||
Other liabilities and expenses | 285 | 311 | ||||||||||||
Total liabilities | $ | 611 | $ | 691 |
Note 8 | Reserve for Property and Casualty Insurance Claims and Claims Expense |
Rollforward of the reserve for property and casualty insurance claims and claims expense | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Balance as of January 1 | $ | 37,541 | $ | 33,060 | ||||||||||
Less recoverables (1) | (9,176) | (9,479) | ||||||||||||
Net balance as of January 1 | 28,365 | 23,581 | ||||||||||||
Incurred claims and claims expense related to: | ||||||||||||||
Current year | 10,341 | 7,677 | ||||||||||||
Prior years | (15) | 145 | ||||||||||||
Total incurred | 10,326 | 7,822 | ||||||||||||
Claims and claims expense paid related to: | ||||||||||||||
Current year | (3,122) | (2,751) | ||||||||||||
Prior years | (6,036) | (4,735) | ||||||||||||
Total paid | (9,158) | (7,486) | ||||||||||||
Net balance as of March 31 | 29,533 | 23,917 | ||||||||||||
Plus recoverables | 9,111 | 9,074 | ||||||||||||
Balance as of March 31 | $ | 38,644 | $ | 32,991 |
Note 9 | Reserve for Future Policy Benefits and Contractholder Funds |
Rollforward of reserve for future policy benefits (1) | ||||||||||||||||||||||||||||||||||||||
Three months ended March 31, | ||||||||||||||||||||||||||||||||||||||
Accident and health | Traditional life | Total | ||||||||||||||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||||||||
Present value of expected net premiums | ||||||||||||||||||||||||||||||||||||||
Beginning balance | $ | 1,464 | $ | 1,785 | $ | 238 | $ | 254 | $ | 1,702 | $ | 2,039 | ||||||||||||||||||||||||||
Beginning balance at original discount rate | 1,549 | 1,604 | 246 | 215 | 1,795 | 1,819 | ||||||||||||||||||||||||||||||||
Effect of changes in cash flow assumptions | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Effect of actual variances from expected experience | (42) | (49) | 5 | 20 | (37) | (29) | ||||||||||||||||||||||||||||||||
Adjusted beginning balance | 1,507 | 1,555 | 251 | 235 | 1,758 | 1,790 | ||||||||||||||||||||||||||||||||
Issuances | 199 | 173 | 17 | 4 | 216 | 177 | ||||||||||||||||||||||||||||||||
Interest accrual | 12 | 12 | 3 | 2 | 15 | 14 | ||||||||||||||||||||||||||||||||
Net premiums collected | (95) | (103) | (12) | (11) | (107) | (114) | ||||||||||||||||||||||||||||||||
Lapses and withdrawals | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Ending balance at original discount rate | 1,623 | 1,637 | 259 | 230 | 1,882 | 1,867 | ||||||||||||||||||||||||||||||||
Effect of changes in discount rate assumptions | (62) | 65 | (5) | 20 | (67) | 85 | ||||||||||||||||||||||||||||||||
Ending balance | 1,561 | 1,702 | 254 | 250 | 1,815 | 1,952 | ||||||||||||||||||||||||||||||||
Present value of expected future policy benefits | ||||||||||||||||||||||||||||||||||||||
Beginning balance | 2,229 | 2,796 | 524 | 673 | 2,753 | 3,469 | ||||||||||||||||||||||||||||||||
Beginning balance at original discount rate | 2,316 | 2,426 | 534 | 511 | 2,850 | 2,937 | ||||||||||||||||||||||||||||||||
Effect of changes in cash flow assumptions | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Effect of actual variances from expected experience | (47) | (53) | 4 | 19 | (43) | (34) | ||||||||||||||||||||||||||||||||
Adjusted beginning balance | 2,269 | 2,373 | 538 | 530 | 2,807 | 2,903 | ||||||||||||||||||||||||||||||||
Issuances | 199 | 172 | 16 | 4 | 215 | 176 | ||||||||||||||||||||||||||||||||
Interest accrual | 19 | 19 | 6 | 5 | 25 | 24 | ||||||||||||||||||||||||||||||||
Benefit payments | (99) | (110) | (12) | (8) | (111) | (118) | ||||||||||||||||||||||||||||||||
Lapses and withdrawals | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Ending balance at original discount rate | 2,388 | 2,454 | 548 | 531 | 2,936 | 2,985 | ||||||||||||||||||||||||||||||||
Effect of changes in discount rate assumptions | (53) | 175 | (1) | 94 | (54) | 269 | ||||||||||||||||||||||||||||||||
Ending balance | $ | 2,335 | $ | 2,629 | $ | 547 | $ | 625 | $ | 2,882 | $ | 3,254 | ||||||||||||||||||||||||||
Net reserve for future policy benefits (1) | $ | 774 | $ | 927 | $ | 293 | $ | 375 | $ | 1,067 | $ | 1,302 | ||||||||||||||||||||||||||
Less: reinsurance recoverables | 76 | 139 | 2 | 2 | 78 | 141 | ||||||||||||||||||||||||||||||||
Net reserve for future policy benefits, after reinsurance recoverables | $ | 698 | $ | 788 | $ | 291 | $ | 373 | $ | 989 | $ | 1,161 |
Revenue and interest recognized in the condensed consolidated statements of operations | ||||||||||||||
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Revenues (1) | ||||||||||||||
Accident and health | $ | 225 | $ | 253 | ||||||||||
Traditional life | 25 | 22 | ||||||||||||
Total | $ | 250 | $ | 275 | ||||||||||
Interest expense (2) | ||||||||||||||
Accident and health | $ | 7 | $ | 7 | ||||||||||
Traditional life | 3 | 3 | ||||||||||||
Total | $ | 10 | $ | 10 |
As of March 31, | ||||||||||||||||||||||||||
2023 | 2022 | |||||||||||||||||||||||||
($ in millions) | Undiscounted | Discounted | Undiscounted | Discounted | ||||||||||||||||||||||
Accident and health | ||||||||||||||||||||||||||
Expected future gross premiums | $ | 5,068 | $ | 3,671 | $ | 5,219 | $ | 4,137 | ||||||||||||||||||
Expected future benefits and expenses | 3,351 | 2,335 | 3,453 | 2,629 | ||||||||||||||||||||||
Traditional life | ||||||||||||||||||||||||||
Expected future gross premiums | 721 | 500 | 652 | 500 | ||||||||||||||||||||||
Expected future benefits and expenses | 1,008 | 547 | 972 | 625 |
As of March 31, | ||||||||||||||||||||||||||
Accident and health | Traditional life | |||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Lapses | 90 | % | 111 | % | 92 | % | 95 | % | ||||||||||||||||||
Contractholder funds activity | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Balance, beginning of year | $ | 879 | $ | 890 | ||||||||||
Deposits | 33 | 35 | ||||||||||||
Interest credited | 8 | 8 | ||||||||||||
Benefits | (4) | (3) | ||||||||||||
Surrenders and partial withdrawals | (5) | (5) | ||||||||||||
Contract charges | (30) | (28) | ||||||||||||
Other adjustments | (3) | (6) | ||||||||||||
Balance, end of period | $ | 878 | $ | 891 | ||||||||||
Components of contractholder funds | ||||||||||||||
Interest-sensitive life insurance | $ | 830 | $ | 837 | ||||||||||
Fixed annuities | 48 | 54 | ||||||||||||
Total | $ | 878 | $ | 891 | ||||||||||
Weighted-average crediting rate | 4.27 | % | 4.29 | % | ||||||||||
Net amount at risk (1) | $ | 11,780 | $ | 12,101 | ||||||||||
Cash surrender value | $ | 722 | $ | 728 |
Note 10 | Reinsurance and Indemnification |
Effects of reinsurance ceded and indemnification programs on property and casualty premiums earned and accident and health insurance premiums and contract charges | ||||||||||||||
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Property and casualty insurance premiums earned | $ | (446) | $ | (427) | ||||||||||
Accident and health insurance premiums and contract charges | (9) | (8) |
Rollforward of credit loss allowance for reinsurance recoverables | ||||||||||||||
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Property and casualty (1) (2) | ||||||||||||||
Beginning balance | $ | (62) | $ | (66) | ||||||||||
Decrease (increase) in the provision for credit losses | 1 | — | ||||||||||||
Write-offs | — | — | ||||||||||||
Ending balance | $ | (61) | $ | (66) | ||||||||||
Accident and health insurance | ||||||||||||||
Beginning balance | $ | (3) | $ | (8) | ||||||||||
Increase in the provision for credit losses | — | — | ||||||||||||
Write-offs | — | — | ||||||||||||
Ending balance | $ | (3) | $ | (8) |
Note 11 | Deferred Policy Acquisition Costs |
Deferred policy acquisition costs activity | ||||||||||||||||||||||||||
($ in millions) | Accident and health | Traditional life | Interest-sensitive life | Total | ||||||||||||||||||||||
Three months ended March 31, 2023 | ||||||||||||||||||||||||||
Accident and health insurance | ||||||||||||||||||||||||||
Long-duration contracts | ||||||||||||||||||||||||||
Beginning balance | $ | 322 | $ | 79 | $ | 101 | $ | 502 | ||||||||||||||||||
Acquisition costs deferred | 13 | 6 | 4 | 23 | ||||||||||||||||||||||
Amortization charged to income | (9) | (3) | (4) | (16) | ||||||||||||||||||||||
Experience adjustment | (9) | — | — | (9) | ||||||||||||||||||||||
Total | $ | 317 | $ | 82 | $ | 101 | 500 | |||||||||||||||||||
Short-duration contracts | 28 | |||||||||||||||||||||||||
Property and casualty | 4,943 | |||||||||||||||||||||||||
Balance, end of year | $ | 5,471 | ||||||||||||||||||||||||
Three months ended March 31, 2022 | ||||||||||||||||||||||||||
Accident and health insurance | ||||||||||||||||||||||||||
Long-duration contracts | ||||||||||||||||||||||||||
Balance, beginning of year | $ | 339 | $ | 47 | $ | 90 | $ | 476 | ||||||||||||||||||
Acquisition costs deferred | 12 | 11 | 8 | 31 | ||||||||||||||||||||||
Amortization charged to income | (7) | (2) | (3) | (12) | ||||||||||||||||||||||
Experience adjustment | (14) | — | — | (14) | ||||||||||||||||||||||
Total | $ | 330 | $ | 56 | $ | 95 | 481 | |||||||||||||||||||
Short-duration contracts | 20 | |||||||||||||||||||||||||
Property and casualty | 4,342 | |||||||||||||||||||||||||
Balance, end of year | $ | 4,843 |
Note 12 | Capital Structure |
Note 13 | Company Restructuring |
Restructuring activity during the period | ||||||||||||||||||||
($ in millions) | Employee costs | Exit costs | Total liability | |||||||||||||||||
Restructuring liability as of December 31, 2022 | $ | 27 | $ | 7 | $ | 34 | ||||||||||||||
Expense incurred | 6 | 28 | 34 | |||||||||||||||||
Adjustments to liability | (2) | (5) | (7) | |||||||||||||||||
Payments and non-cash charges | (16) | (28) | (44) | |||||||||||||||||
Restructuring liability as of March 31, 2023 | $ | 15 | $ | 2 | $ | 17 |
Note 14 | Guarantees and Contingent Liabilities |
Note 15 | Benefit Plans |
Components of net cost (benefit) for pension and other postretirement plans | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Pension benefits | ||||||||||||||
Service cost | $ | 33 | $ | 29 | ||||||||||
Interest cost | 60 | 46 | ||||||||||||
Expected return on plan assets | (77) | (110) | ||||||||||||
Amortization of prior service credit | — | (13) | ||||||||||||
Costs and expenses | 16 | (48) | ||||||||||||
Remeasurement of projected benefit obligation | 123 | (752) | ||||||||||||
Remeasurement of plan assets | (180) | 529 | ||||||||||||
Remeasurement (gains) losses | (57) | (223) | ||||||||||||
Pension net benefit | $ | (41) | $ | (271) | ||||||||||
Postretirement benefits | ||||||||||||||
Service cost | $ | — | $ | — | ||||||||||
Interest cost | 3 | 2 | ||||||||||||
Amortization of prior service credit | (6) | (6) | ||||||||||||
Costs and expenses | (3) | (4) | ||||||||||||
Remeasurement of projected benefit obligation | 4 | (24) | ||||||||||||
Remeasurement of plan assets | — | — | ||||||||||||
Remeasurement (gains) losses | 4 | (24) | ||||||||||||
Postretirement net cost (benefit) | $ | 1 | $ | (28) | ||||||||||
Pension and postretirement benefits | ||||||||||||||
Costs and expenses | $ | 13 | $ | (52) | ||||||||||
Remeasurement (gains) losses | (53) | (247) | ||||||||||||
Total net benefit | $ | (40) | $ | (299) |
Pension and postretirement benefits remeasurement gains and losses | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Remeasurement of projected benefit obligation (gains) losses: | ||||||||||||||
Discount rate | $ | 124 | $ | (585) | ||||||||||
Other assumptions | 3 | (191) | ||||||||||||
Remeasurement of plan assets (gains) losses | (180) | 529 | ||||||||||||
Remeasurement (gains) losses | $ | (53) | $ | (247) |
Note 16 | Supplemental Cash Flow Information |
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Net change in proceeds managed | ||||||||||||||
Net change in fixed income securities | $ | 111 | $ | — | ||||||||||
Net change in short-term investments | 93 | (63) | ||||||||||||
Operating cash flow provided (used) | 204 | (63) | ||||||||||||
Net change in cash | — | 3 | ||||||||||||
Net change in proceeds managed | $ | 204 | $ | (60) | ||||||||||
Cash flows from operating activities | ||||||||||||||
Net change in liabilities | ||||||||||||||
Liabilities for collateral, beginning of period | $ | (2,011) | $ | (1,444) | ||||||||||
Liabilities for collateral, end of period | (1,807) | (1,504) | ||||||||||||
Operating cash flow (used) provided | $ | (204) | $ | 60 |
Note 17 | Other Comprehensive Income (Loss) |
Components of other comprehensive income (loss) on a pre-tax and after-tax basis | ||||||||||||||||||||||||||||||||||||||
($ in millions) | Three months ended March 31, | |||||||||||||||||||||||||||||||||||||
2023 | 2022 | |||||||||||||||||||||||||||||||||||||
Pre-tax | Tax | After-tax | Pre-tax | Tax | After-tax | |||||||||||||||||||||||||||||||||
Unrealized net holding gains and losses arising during the period, net of related offsets | $ | 729 | $ | (156) | $ | 573 | $ | (2,149) | $ | 458 | $ | (1,691) | ||||||||||||||||||||||||||
Less: reclassification adjustment of realized capital gains and losses | (138) | 29 | (109) | (123) | 26 | (97) | ||||||||||||||||||||||||||||||||
Unrealized net capital gains and losses | 867 | (185) | 682 | (2,026) | 432 | (1,594) | ||||||||||||||||||||||||||||||||
Unrealized foreign currency translation adjustments | 63 | (13) | 50 | — | — | — | ||||||||||||||||||||||||||||||||
Unamortized pension and other postretirement prior service credit (1) | (6) | 2 | (4) | (19) | 4 | (15) | ||||||||||||||||||||||||||||||||
Discount rate for reserve for future policy benefits | (11) | 2 | (9) | 120 | (25) | 95 | ||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | $ | 913 | $ | (194) | $ | 719 | $ | (1,925) | $ | 411 | $ | (1,514) | ||||||||||||||||||||||||||
• | Net gains and losses on investments and derivatives | ||||
• | Pension and other postretirement remeasurement gains and losses | ||||
• | Amortization or impairment of purchased intangibles | ||||
• | Gain or loss on disposition | ||||
• | Adjustments for other significant non-recurring, infrequent or unusual items, when (a) the nature of the charge or gain is such that it is reasonably unlikely to recur within two years, or (b) there has been no similar charge or gain within the prior two years | ||||
• | Income tax expense or benefit on reconciling items |
Consolidated net income (loss) applicable to common shareholders | ||||||||||||||
($ in millions) | ||||||||||||||
Consolidated net loss applicable to common shareholders was $346 million in the first quarter of 2023 compared to income of $634 million in the first quarter of 2022, primarily due to higher losses driven by severity and frequency and higher catastrophe losses, partially offset by increased Property-Liability premiums earned. For the twelve months ended March 31, 2023, return on Allstate common shareholders’ equity was (13.0)%, a decrease of 28.6 points from 15.6% for the twelve months ended March 31, 2022. | ||
Total revenue | ||||||||||||||
($ in millions) |
Total revenue increased 11.8% to $13.79 billion in the first quarter of 2023 compared to the first quarter of 2022 due to an increase of 10.9% in property and casualty insurance premiums earned in the first quarter of 2023 compared to the first quarter of 2022 and net gains on investments and derivatives in 2023 compared to net losses in 2022. |
Net investment income | ||||||||||||||
($ in millions) |
Net investment income decreased $19 million to $575 million in the first quarter of 2023 compared to the first quarter of 2022, primarily due to lower performance-based investment results, mainly from limited partnerships, largely offset by higher market-based income. Market-based reflects higher fixed income portfolio yields and balance. |
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Revenues | ||||||||||||||
Property and casualty insurance premiums | $ | 12,173 | $ | 10,981 | ||||||||||
Accident and health insurance premiums and contract charges | 463 | 468 | ||||||||||||
Other revenue | 561 | 560 | ||||||||||||
Net investment income | 575 | 594 | ||||||||||||
Net gains (losses) on investments and derivatives | 14 | (267) | ||||||||||||
Total revenues | 13,786 | 12,336 | ||||||||||||
Costs and expenses | ||||||||||||||
Property and casualty insurance claims and claims expense | (10,326) | (7,822) | ||||||||||||
Accident, health and other policy benefits | (265) | (268) | ||||||||||||
Amortization of deferred policy acquisition costs | (1,744) | (1,608) | ||||||||||||
Operating, restructuring and interest expenses | (1,829) | (1,997) | ||||||||||||
Pension and other postretirement remeasurement gains (losses) | 53 | 247 | ||||||||||||
Amortization of purchased intangibles | (81) | (87) | ||||||||||||
Total costs and expenses | (14,192) | (11,535) | ||||||||||||
(Loss) income from operations before income tax expense | (406) | 801 | ||||||||||||
Income tax benefit (expense) | 85 | (151) | ||||||||||||
Net (loss) income | (321) | 650 | ||||||||||||
Less: Net loss attributable to noncontrolling interest | (1) | (10) | ||||||||||||
Net (loss) income attributable to Allstate | (320) | 660 | ||||||||||||
Preferred stock dividends | (26) | (26) | ||||||||||||
Net (loss) income applicable to common shareholders | $ | (346) | $ | 634 |
After-tax cumulative effect of change in accounting principle on transition date | ||||||||
($ in millions) | January 1, 2021 | |||||||
Decrease in retained income | $ | 21 | ||||||
Decrease in accumulated other comprehensive income (“AOCI”) | 277 | |||||||
Total decrease in equity | $ | 298 |
Underwriting results | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions, except ratios) | 2023 | 2022 | ||||||||||||
Premiums written | $ | 11,783 | $ | 10,761 | ||||||||||
Premiums earned | $ | 11,635 | $ | 10,498 | ||||||||||
Other revenue | 353 | 347 | ||||||||||||
Claims and claims expense | (10,180) | (7,702) | ||||||||||||
Amortization of DAC | (1,452) | (1,348) | ||||||||||||
Other costs and expenses | (1,279) | (1,445) | ||||||||||||
Restructuring and related charges (1) | (21) | (12) | ||||||||||||
Amortization of purchased intangibles | (57) | (58) | ||||||||||||
Underwriting (loss) income | $ | (1,001) | $ | 280 | ||||||||||
Catastrophe losses | ||||||||||||||
Catastrophe losses, excluding reserve reestimates | $ | 1,733 | $ | 475 | ||||||||||
Catastrophe reserve reestimates (2) | (42) | (13) | ||||||||||||
Total catastrophe losses | $ | 1,691 | $ | 462 | ||||||||||
Non-catastrophe reserve reestimates (2) | 27 | 158 | ||||||||||||
Prior year reserve reestimates (2) | (15) | 145 | ||||||||||||
GAAP operating ratios | ||||||||||||||
Loss ratio | 87.5 | 73.3 | ||||||||||||
Expense ratio (3) | 21.1 | 24.0 | ||||||||||||
Combined ratio | 108.6 | 97.3 | ||||||||||||
Effect of catastrophe losses on combined ratio | 14.5 | 4.4 | ||||||||||||
Effect of prior year reserve reestimates on combined ratio | (0.1) | 1.4 | ||||||||||||
Effect of catastrophe losses included in prior year reserve reestimates on combined ratio | (0.4) | (0.1) | ||||||||||||
Effect of restructuring and related charges on combined ratio (1) | 0.2 | 0.1 | ||||||||||||
Effect of amortization of purchased intangibles on combined ratio | 0.5 | 0.5 | ||||||||||||
Underwriting results | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Premiums written | $ | 11,783 | $ | 10,761 | ||||||||||
Premiums earned | $ | 11,635 | $ | 10,498 | ||||||||||
Other revenue | 353 | 347 | ||||||||||||
Claims and claims expense | (10,178) | (7,701) | ||||||||||||
Amortization of DAC | (1,452) | (1,348) | ||||||||||||
Other costs and expenses | (1,278) | (1,444) | ||||||||||||
Restructuring and related charges | (21) | (12) | ||||||||||||
Amortization of purchased intangibles | (57) | (58) | ||||||||||||
Underwriting (loss) income | $ | (998) | $ | 282 | ||||||||||
Catastrophe losses | $ | 1,691 | $ | 462 | ||||||||||
Change in underwriting results from prior year period - three months ended | ||||||||||||||
($ in millions) |
Premiums written by brand and by line of business | ||||||||||||||||||||||||||||||||||||||
Allstate brand | National General | Allstate Protection | ||||||||||||||||||||||||||||||||||||
($ in millions) | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||||||||
Three months ended March 31, | ||||||||||||||||||||||||||||||||||||||
Auto | $ | 6,826 | $ | 6,308 | $ | 1,523 | $ | 1,254 | $ | 8,349 | $ | 7,562 | ||||||||||||||||||||||||||
Homeowners | 2,210 | 2,020 | 324 | 261 | 2,534 | 2,281 | ||||||||||||||||||||||||||||||||
Other personal lines | 492 | 469 | 56 | 35 | 548 | 504 | ||||||||||||||||||||||||||||||||
Commercial lines | 177 | 238 | 50 | 56 | 227 | 294 | ||||||||||||||||||||||||||||||||
Other business lines | — | — | 125 | 120 | 125 | 120 | ||||||||||||||||||||||||||||||||
Total premiums written | $ | 9,705 | $ | 9,035 | $ | 2,078 | $ | 1,726 | $ | 11,783 | $ | 10,761 | ||||||||||||||||||||||||||
Policies in force by brand and by line of business | ||||||||||||||||||||||||||||||||||||||
Allstate brand | National General | Allstate Protection | ||||||||||||||||||||||||||||||||||||
PIF (thousands) | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||||||||
Auto | 21,142 | 21,968 | 4,591 | 4,103 | 25,733 | 26,071 | ||||||||||||||||||||||||||||||||
Homeowners | 6,621 | 6,536 | 641 | 629 | 7,262 | 7,165 | ||||||||||||||||||||||||||||||||
Other personal lines | 4,607 | 4,609 | 306 | 285 | 4,913 | 4,894 | ||||||||||||||||||||||||||||||||
Commercial lines | 199 | 208 | 108 | 104 | 307 | 312 | ||||||||||||||||||||||||||||||||
Total | 32,569 | 33,321 | 5,646 | 5,121 | 38,215 | 38,442 |
Auto premium measures and statistics | ||||||||||||||||||||
Three months ended March 31, | ||||||||||||||||||||
2023 | 2022 | Change | ||||||||||||||||||
New issued applications (thousands) | ||||||||||||||||||||
Allstate Protection by brand | ||||||||||||||||||||
Allstate brand | 751 | 964 | (22.1) | % | ||||||||||||||||
National General | 783 | 718 | 9.1 | % | ||||||||||||||||
Total new issued applications | 1,534 | 1,682 | (8.8) | % | ||||||||||||||||
Allstate Protection by channel | ||||||||||||||||||||
Exclusive agency channel | 589 | 599 | (1.7) | % | ||||||||||||||||
Direct channel | 463 | 631 | (26.6) | % | ||||||||||||||||
Independent agency channel | 482 | 452 | 6.6 | % | ||||||||||||||||
Total new issued applications | 1,534 | 1,682 | (8.8) | % | ||||||||||||||||
Allstate brand average premium | $ | 726 | $ | 626 | 16.0 | % | ||||||||||||||
Allstate brand renewal ratio (%) | 85.7 | 87.5 | (1.8) | |||||||||||||||||
Combined ratios by line of business | ||||||||||||||||||||||||||||||||||||||
Loss ratio | Expense ratio (1) | Combined ratio | ||||||||||||||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||||||||||||
Three months ended March 31, | ||||||||||||||||||||||||||||||||||||||
Auto | 83.4 | 77.6 | 21.0 | 24.5 | 104.4 | 102.1 | ||||||||||||||||||||||||||||||||
Homeowners | 98.5 | 61.8 | 20.5 | 22.1 | 119.0 | 83.9 | ||||||||||||||||||||||||||||||||
Other personal lines | 93.8 | 72.1 | 22.0 | 24.5 | 115.8 | 96.6 | ||||||||||||||||||||||||||||||||
Commercial lines | 102.2 | 87.3 | 23.7 | 20.5 | 125.9 | 107.8 | ||||||||||||||||||||||||||||||||
Other business lines | 43.1 | 31.0 | 33.3 | 41.6 | 76.4 | 72.6 | ||||||||||||||||||||||||||||||||
Total | 87.5 | 73.3 | 21.1 | 24.0 | 108.6 | 97.3 | ||||||||||||||||||||||||||||||||
Impact of amortization of purchased intangibles | — | — | 0.5 | 0.5 | 0.5 | 0.5 | ||||||||||||||||||||||||||||||||
Impact of restructuring and related charges | — | — | 0.2 | 0.1 | 0.2 | 0.1 | ||||||||||||||||||||||||||||||||
Loss ratios by line of business | ||||||||||||||||||||||||||||||||||||||||||||||||||
Loss ratio | Effect of catastrophe losses (1) | Effect of prior year reserve reestimates | Effect of catastrophe losses included in prior year reserve reestimates | |||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||||||||||||||||||||||
Three months ended March 31, | ||||||||||||||||||||||||||||||||||||||||||||||||||
Auto | 83.4 | 77.6 | 1.2 | 0.6 | (0.3) | 2.0 | (0.4) | (0.1) | ||||||||||||||||||||||||||||||||||||||||||
Homeowners | 98.5 | 61.8 | 51.6 | 15.4 | (0.7) | (0.3) | (0.2) | (0.4) | ||||||||||||||||||||||||||||||||||||||||||
Other personal lines | 93.8 | 72.1 | 23.8 | 6.4 | 0.5 | (1.3) | (1.3) | 0.8 | ||||||||||||||||||||||||||||||||||||||||||
Commercial lines | 102.2 | 87.3 | 3.9 | — | 10.3 | 6.7 | 0.4 | (0.4) | ||||||||||||||||||||||||||||||||||||||||||
Other business lines | 43.1 | 31.0 | 4.9 | 1.8 | 0.8 | (2.7) | — | 3.5 | ||||||||||||||||||||||||||||||||||||||||||
Total | 87.5 | 73.3 | 14.5 | 4.4 | (0.1) | 1.4 | (0.4) | (0.1) | ||||||||||||||||||||||||||||||||||||||||||
Auto underwriting results | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
For the periods ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
($ in millions, except ratios) | Q1 | Q4 | Q3 | Q2 | Q1 | Q4 | Q3 | Q2 | Q1 | |||||||||||||||||||||||||||||||||||||||||||||||
Underwriting income (loss) | (346) | (974) | (1,315) | (578) | (147) | (300) | (159) | 394 | 1,327 | |||||||||||||||||||||||||||||||||||||||||||||||
Loss ratio | 83.4 | 90.6 | 95.3 | 84.9 | 77.6 | 78.9 | 76.9 | 68.7 | 57.2 | |||||||||||||||||||||||||||||||||||||||||||||||
Effect of prior year non-catastrophe reserve reestimates | (0.1) | 2.3 | 8.5 | 3.8 | 2.1 | 2.1 | 1.1 | (0.4) | (0.2) |
Allstate brand homeowners frequency and severity statistics (excluding catastrophe losses) | ||||||||
(% change year-over-year) | ||||||||
Three months ended March 31, 2023 | ||||||||
Gross claim frequency | 1.3 | % | ||||||
Paid claim severity | 10.9 | |||||||
Catastrophe losses by the type of event | ||||||||||||||||||||||||||
Three months ended March 31, | ||||||||||||||||||||||||||
($ in millions) | Number of events | 2023 | Number of events | 2022 | ||||||||||||||||||||||
Tornadoes | 2 | $ | 133 | 1 | $ | 91 | ||||||||||||||||||||
Wind/Hail | 22 | 1,498 | 14 | 365 | ||||||||||||||||||||||
Freeze/other events | 4 | 102 | 1 | 19 | ||||||||||||||||||||||
Prior year reserve reestimates | (42) | (13) | ||||||||||||||||||||||||
Total catastrophe losses | 28 | $ | 1,691 | 16 | $ | 462 |
Prior year reserve reestimates | ||||||||||||||||||||||||||
Three months ended March 31, | ||||||||||||||||||||||||||
Prior year reserve reestimates (1) | Effect on combined ratio (2) | |||||||||||||||||||||||||
($ in millions, except ratios) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Auto | $ | (25) | $ | 142 | (0.2) | 1.4 | ||||||||||||||||||||
Homeowners | (20) | (7) | (0.1) | (0.1) | ||||||||||||||||||||||
Other personal lines | 3 | (7) | — | (0.1) | ||||||||||||||||||||||
Commercial lines | 24 | 19 | 0.2 | 0.2 | ||||||||||||||||||||||
Other business lines | 1 | (3) | — | — | ||||||||||||||||||||||
Total Allstate Protection | $ | (17) | $ | 144 | (0.1) | 1.4 | ||||||||||||||||||||
Allstate brand | $ | (54) | $ | 148 | (0.4) | 1.4 | ||||||||||||||||||||
National General | 37 | (4) | 0.3 | — | ||||||||||||||||||||||
Total Allstate Protection | $ | (17) | $ | 144 | (0.1) | 1.4 |
Underwriting results | ||||||||||||||
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Claims and claims expense | $ | (2) | $ | (1) | ||||||||||
Operating costs and expenses | (1) | (1) | ||||||||||||
Underwriting loss | $ | (3) | $ | (2) |
Percentage of gross and ceded reserves by case and IBNR | ||||||||||||||||||||||||||
March 31, 2023 | December 31, 2022 | |||||||||||||||||||||||||
Case | IBNR | Case | IBNR | |||||||||||||||||||||||
Direct excess commercial insurance | ||||||||||||||||||||||||||
Gross reserves (1) | 57 | % | 43 | % | 58 | % | 42 | % | ||||||||||||||||||
Ceded (2) | 62 | 38 | 63 | 37 | ||||||||||||||||||||||
Assumed reinsurance coverage | ||||||||||||||||||||||||||
Gross reserves | 30 | 70 | 31 | 69 | ||||||||||||||||||||||
Ceded | 32 | 68 | 33 | 67 | ||||||||||||||||||||||
Direct primary commercial insurance | ||||||||||||||||||||||||||
Gross reserves | 58 | 42 | 57 | 43 | ||||||||||||||||||||||
Ceded | 81 | 19 | 81 | 19 |
Gross payments from case reserves by type of exposure | ||||||||||||||
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Direct excess commercial insurance | ||||||||||||||
Gross (1) | $ | 23 | $ | 18 | ||||||||||
Ceded (2) | (5) | (7) | ||||||||||||
Assumed reinsurance coverage | ||||||||||||||
Gross | 5 | 6 | ||||||||||||
Ceded | (1) | (1) | ||||||||||||
Direct primary commercial insurance | ||||||||||||||
Gross | 1 | 1 | ||||||||||||
Ceded | — | — | ||||||||||||
Summarized financial information | ||||||||||||||
($ in millions) | Three months ended March 31, | |||||||||||||
2023 | 2022 | |||||||||||||
Premiums written | $ | 619 | $ | 630 | ||||||||||
Revenues | ||||||||||||||
Premiums | $ | 538 | $ | 483 | ||||||||||
Other revenue | 84 | 94 | ||||||||||||
Intersegment insurance premiums and service fees (1) | 33 | 41 | ||||||||||||
Net investment income | 16 | 9 | ||||||||||||
Costs and expenses | ||||||||||||||
Claims and claims expense | (153) | (123) | ||||||||||||
Amortization of DAC | (251) | (221) | ||||||||||||
Operating costs and expenses | (221) | (218) | ||||||||||||
Restructuring and related charges | (1) | — | ||||||||||||
Income tax expense on operations | (11) | (12) | ||||||||||||
Less: noncontrolling interest | — | — | ||||||||||||
Adjusted net income | $ | 34 | $ | 53 | ||||||||||
Allstate Protection Plans | $ | 28 | $ | 43 | ||||||||||
Allstate Dealer Services | 7 | 9 | ||||||||||||
Allstate Roadside | 4 | 2 | ||||||||||||
Arity | (4) | (1) | ||||||||||||
Allstate Identity Protection | (1) | — | ||||||||||||
Adjusted net income | $ | 34 | $ | 53 | ||||||||||
Allstate Protection Plans | 136,591 | 139,992 | ||||||||||||
Allstate Dealer Services | 3,839 | 3,924 | ||||||||||||
Allstate Roadside | 536 | 518 | ||||||||||||
Allstate Identity Protection | 3,206 | 2,949 | ||||||||||||
Policies in force as of March 31 (in thousands) | 144,172 | 147,383 |
Summarized financial information | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Revenues | ||||||||||||||
Accident and health insurance premiums and contract charges | $ | 463 | $ | 468 | ||||||||||
Other revenue | 101 | 95 | ||||||||||||
Net investment income | 19 | 17 | ||||||||||||
Costs and expenses | ||||||||||||||
Accident, health and other policy benefits | (265) | (268) | ||||||||||||
Amortization of DAC | (41) | (39) | ||||||||||||
Operating costs and expenses | (203) | (202) | ||||||||||||
Restructuring and related charges | (4) | — | ||||||||||||
Income tax expense on operations | (14) | (14) | ||||||||||||
Adjusted net income | $ | 56 | $ | 57 | ||||||||||
Benefit ratio (1) | 55.5 | 55.6 | ||||||||||||
Employer voluntary benefits (2) | 3,799 | 3,951 | ||||||||||||
Group health (3) | 127 | 114 | ||||||||||||
Individual health (4) | 413 | 419 | ||||||||||||
Policies in force as of March 31 (in thousands) | 4,339 | 4,484 |
Premiums and contract charges by line of business | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Employer voluntary benefits | $ | 255 | $ | 263 | ||||||||||
Group health | 107 | 94 | ||||||||||||
Individual health | 101 | 111 | ||||||||||||
Premiums and contract charges | $ | 463 | $ | 468 |
Operating costs and expenses | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Non-deferrable commissions | $ | 79 | $ | 81 | ||||||||||
General and administrative expenses | 124 | 121 | ||||||||||||
Total operating costs and expenses | $ | 203 | $ | 202 |
Portfolio composition and strategy by reporting segment (1) | ||||||||||||||||||||||||||||||||
March 31, 2023 | ||||||||||||||||||||||||||||||||
($ in millions) | Property-Liability | Protection Services | Allstate Health and Benefits | Corporate and Other | Total | |||||||||||||||||||||||||||
Fixed income securities (2) | $ | 37,940 | $ | 1,825 | $ | 1,591 | $ | 2,747 | $ | 44,103 | ||||||||||||||||||||||
Equity securities (3) | 1,468 | 109 | 43 | 554 | 2,174 | |||||||||||||||||||||||||||
Mortgage loans, net | 685 | — | 96 | — | 781 | |||||||||||||||||||||||||||
Limited partnership interests | 7,955 | — | — | 16 | 7,971 | |||||||||||||||||||||||||||
Short-term investments (4) | 5,663 | 151 | 91 | 817 | 6,722 | |||||||||||||||||||||||||||
Other investments, net | 1,601 | — | 120 | 3 | 1,724 | |||||||||||||||||||||||||||
Total | $ | 55,312 | $ | 2,085 | $ | 1,941 | $ | 4,137 | $ | 63,475 | ||||||||||||||||||||||
Percent to total | 87.1 | % | 3.3 | % | 3.1 | % | 6.5 | % | 100.0 | % | ||||||||||||||||||||||
Market-based | $ | 46,156 | $ | 2,085 | $ | 1,941 | $ | 4,134 | $ | 54,316 | ||||||||||||||||||||||
Performance-based | 9,156 | — | — | 3 | 9,159 | |||||||||||||||||||||||||||
Total | $ | 55,312 | $ | 2,085 | $ | 1,941 | $ | 4,137 | $ | 63,475 |
Fixed income securities by type | ||||||||||||||
Fair value as of | ||||||||||||||
($ in millions) | March 31, 2023 | December 31, 2022 | ||||||||||||
U.S. government and agencies | $ | 7,695 | $ | 7,898 | ||||||||||
Municipal | 6,324 | 6,210 | ||||||||||||
Corporate | 28,036 | 26,263 | ||||||||||||
Foreign government | 1,091 | 957 | ||||||||||||
Asset-backed securities (“ABS”) | 957 | 1,157 | ||||||||||||
Total fixed income securities | $ | 44,103 | $ | 42,485 |
Fair value and unrealized net capital gains (losses) for fixed income securities by credit rating | ||||||||||||||||||||||||||||||||||||||
March 31, 2023 | ||||||||||||||||||||||||||||||||||||||
NAIC 1 | NAIC 2 | NAIC 3 | ||||||||||||||||||||||||||||||||||||
A and above | BBB | BB | ||||||||||||||||||||||||||||||||||||
($ in millions) | Fair value | Unrealized gain (loss) | Fair value | Unrealized gain (loss) | Fair value | Unrealized gain (loss) | ||||||||||||||||||||||||||||||||
U.S. government and agencies | $ | 7,695 | $ | (131) | $ | — | $ | — | $ | — | $ | — | ||||||||||||||||||||||||||
Municipal | 6,181 | (168) | 129 | (10) | 7 | — | ||||||||||||||||||||||||||||||||
Corporate | ||||||||||||||||||||||||||||||||||||||
Public | 5,863 | (207) | 13,491 | (768) | 829 | (70) | ||||||||||||||||||||||||||||||||
Privately placed | 1,778 | (93) | 3,010 | (211) | 1,487 | (136) | ||||||||||||||||||||||||||||||||
Total corporate | 7,641 | (300) | 16,501 | (979) | 2,316 | (206) | ||||||||||||||||||||||||||||||||
Foreign government | 1,090 | (21) | 1 | — | — | — | ||||||||||||||||||||||||||||||||
ABS | 890 | (19) | 13 | (1) | 9 | (1) | ||||||||||||||||||||||||||||||||
Total fixed income securities | $ | 23,497 | $ | (639) | $ | 16,644 | $ | (990) | $ | 2,332 | $ | (207) | ||||||||||||||||||||||||||
NAIC 4 | NAIC 5-6 | Total | ||||||||||||||||||||||||||||||||||||
B | CCC and lower | |||||||||||||||||||||||||||||||||||||
Fair value | Unrealized gain (loss) | Fair value | Unrealized gain (loss) | Fair value | Unrealized gain (loss) | |||||||||||||||||||||||||||||||||
U.S. government and agencies | $ | — | $ | — | $ | — | $ | — | $ | 7,695 | $ | (131) | ||||||||||||||||||||||||||
Municipal | — | — | 7 | 3 | 6,324 | (175) | ||||||||||||||||||||||||||||||||
Corporate | ||||||||||||||||||||||||||||||||||||||
Public | 166 | (13) | — | — | 20,349 | (1,058) | ||||||||||||||||||||||||||||||||
Privately placed | 1,286 | (142) | 126 | (29) | 7,687 | (611) | ||||||||||||||||||||||||||||||||
Total corporate | 1,452 | (155) | 126 | (29) | 28,036 | (1,669) | ||||||||||||||||||||||||||||||||
Foreign government | — | — | — | — | 1,091 | (21) | ||||||||||||||||||||||||||||||||
ABS | — | — | 45 | — | 957 | (21) | ||||||||||||||||||||||||||||||||
Total fixed income securities | $ | 1,452 | $ | (155) | $ | 178 | $ | (26) | $ | 44,103 | $ | (2,017) |
Unrealized net capital gains (losses) | ||||||||||||||
March 31, | December 31, | |||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
U.S. government and agencies | $ | (131) | $ | (225) | ||||||||||
Municipal | (175) | (290) | ||||||||||||
Corporate | (1,669) | (2,299) | ||||||||||||
Foreign government | (21) | (40) | ||||||||||||
ABS | (21) | (31) | ||||||||||||
Fixed income securities | (2,017) | (2,885) | ||||||||||||
Short-term investments | — | (1) | ||||||||||||
Derivatives | (2) | (3) | ||||||||||||
Equity method of accounting (“EMA”) limited partnerships | 4 | 2 | ||||||||||||
Unrealized net capital gains and losses, pre-tax | $ | (2,015) | $ | (2,887) |
Gross unrealized gains (losses) on fixed income securities by type and sector | ||||||||||||||||||||||||||
March 31, 2023 | ||||||||||||||||||||||||||
($ in millions) | Amortized cost, net | Gross unrealized | Fair value | |||||||||||||||||||||||
Gains | Losses | |||||||||||||||||||||||||
Corporate | ||||||||||||||||||||||||||
Banking | $ | 4,534 | $ | 12 | $ | (244) | $ | 4,302 | ||||||||||||||||||
Basic industry | 999 | 3 | (60) | 942 | ||||||||||||||||||||||
Capital goods | 2,465 | 10 | (142) | 2,333 | ||||||||||||||||||||||
Communications | 2,429 | 3 | (201) | 2,231 | ||||||||||||||||||||||
Consumer goods (cyclical and non-cyclical) | 6,315 | 28 | (383) | 5,960 | ||||||||||||||||||||||
Financial services | 2,304 | 8 | (143) | 2,169 | ||||||||||||||||||||||
Energy | ||||||||||||||||||||||||||
Midstream | 1,877 | 7 | (74) | 1,810 | ||||||||||||||||||||||
Independent/upstream | 320 | 2 | (19) | 303 | ||||||||||||||||||||||
Integrated | 52 | — | (3) | 49 | ||||||||||||||||||||||
Other | 238 | 1 | (10) | 229 | ||||||||||||||||||||||
Total energy | 2,487 | 10 | (106) | 2,391 | ||||||||||||||||||||||
Technology | 3,062 | 7 | (229) | 2,840 | ||||||||||||||||||||||
Transportation | 1,008 | 2 | (55) | 955 | ||||||||||||||||||||||
Utilities | 3,780 | 35 | (170) | 3,645 | ||||||||||||||||||||||
Other | 322 | — | (54) | 268 | ||||||||||||||||||||||
Total corporate fixed income portfolio | 29,705 | 118 | (1,787) | 28,036 | ||||||||||||||||||||||
U.S. government and agencies | 7,826 | 21 | (152) | 7,695 | ||||||||||||||||||||||
Municipal | 6,499 | 65 | (240) | 6,324 | ||||||||||||||||||||||
Foreign government | 1,112 | 3 | (24) | 1,091 | ||||||||||||||||||||||
ABS | 978 | 4 | (25) | 957 | ||||||||||||||||||||||
Total fixed income securities | $ | 46,120 | $ | 211 | $ | (2,228) | $ | 44,103 |
December 31, 2022 | ||||||||||||||||||||||||||
($ in millions) | Amortized cost, net | Gross unrealized | Fair value | |||||||||||||||||||||||
Gains | Losses | |||||||||||||||||||||||||
Corporate | ||||||||||||||||||||||||||
Banking | $ | 5,153 | $ | 16 | $ | (314) | $ | 4,855 | ||||||||||||||||||
Basic industry | 1,019 | 2 | (75) | 946 | ||||||||||||||||||||||
Capital goods | 2,288 | 3 | (197) | 2,094 | ||||||||||||||||||||||
Communications | 2,422 | 1 | (261) | 2,162 | ||||||||||||||||||||||
Consumer goods (cyclical and non-cyclical) | 5,984 | 6 | (531) | 5,459 | ||||||||||||||||||||||
Financial services | 2,243 | 4 | (176) | 2,071 | ||||||||||||||||||||||
Energy | ||||||||||||||||||||||||||
Midstream | 1,725 | 1 | (110) | 1,616 | ||||||||||||||||||||||
Independent/upstream | 354 | 1 | (29) | 326 | ||||||||||||||||||||||
Integrated | 67 | — | (4) | 63 | ||||||||||||||||||||||
Other | 218 | — | (13) | 205 | ||||||||||||||||||||||
Total energy | 2,364 | 2 | (156) | 2,210 | ||||||||||||||||||||||
Technology | 3,137 | 4 | (298) | 2,843 | ||||||||||||||||||||||
Transportation | 959 | 1 | (73) | 887 | ||||||||||||||||||||||
Utilities | 2,633 | 7 | (203) | 2,437 | ||||||||||||||||||||||
Other | 360 | — | (61) | 299 | ||||||||||||||||||||||
Total corporate fixed income portfolio | 28,562 | 46 | (2,345) | 26,263 | ||||||||||||||||||||||
U.S. government and agencies | 8,123 | 6 | (231) | 7,898 | ||||||||||||||||||||||
Municipal | 6,500 | 36 | (326) | 6,210 | ||||||||||||||||||||||
Foreign government | 997 | — | (40) | 957 | ||||||||||||||||||||||
ABS | 1,188 | 4 | (35) | 1,157 | ||||||||||||||||||||||
Total fixed income securities | $ | 45,370 | $ | 92 | $ | (2,977) | $ | 42,485 |
Equity securities by sector | ||||||||||||||||||||||||||||||||||||||
March 31, 2023 | December 31, 2022 | |||||||||||||||||||||||||||||||||||||
($ in millions) | Cost | Over (under) cost | Fair value | Cost | Over (under) cost | Fair value | ||||||||||||||||||||||||||||||||
Banking | $ | 40 | $ | 33 | $ | 73 | $ | 135 | $ | 56 | $ | 191 | ||||||||||||||||||||||||||
Basic Industry | 13 | 2 | 15 | 57 | 16 | 73 | ||||||||||||||||||||||||||||||||
Capital Goods | 85 | (36) | 49 | 196 | 3 | 199 | ||||||||||||||||||||||||||||||||
Energy | ||||||||||||||||||||||||||||||||||||||
Independent/upstream | 9 | 1 | 10 | 30 | 12 | 42 | ||||||||||||||||||||||||||||||||
Integrated | 8 | 3 | 11 | 39 | 26 | 65 | ||||||||||||||||||||||||||||||||
Midstream | 30 | (2) | 28 | 33 | (2) | 31 | ||||||||||||||||||||||||||||||||
Other | 1 | 1 | 2 | 8 | 8 | 16 | ||||||||||||||||||||||||||||||||
Total energy | 48 | 3 | 51 | 110 | 44 | 154 | ||||||||||||||||||||||||||||||||
Funds | ||||||||||||||||||||||||||||||||||||||
Equities | 210 | (10) | 200 | 904 | (19) | 885 | ||||||||||||||||||||||||||||||||
Fixed income | 1,116 | (68) | 1,048 | 1,067 | (84) | 983 | ||||||||||||||||||||||||||||||||
Other | 3 | — | 3 | 3 | — | 3 | ||||||||||||||||||||||||||||||||
Total funds | 1,329 | (78) | 1,251 | 1,974 | (103) | 1,871 | ||||||||||||||||||||||||||||||||
Utilities | 49 | 1 | 50 | 67 | 12 | 79 | ||||||||||||||||||||||||||||||||
Transportation | 20 | 13 | 33 | 48 | 19 | 67 | ||||||||||||||||||||||||||||||||
Other (1) | 563 | 89 | 652 | 1,666 | 267 | 1,933 | ||||||||||||||||||||||||||||||||
Total equity securities | $ | 2,147 | $ | 27 | $ | 2,174 | $ | 4,253 | $ | 314 | $ | 4,567 |
Net investment income | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Fixed income securities | $ | 390 | $ | 267 | ||||||||||
Equity securities | 11 | 36 | ||||||||||||
Mortgage loans | 8 | 8 | ||||||||||||
Limited partnership interests | 134 | 292 | ||||||||||||
Short-term investments | 66 | 2 | ||||||||||||
Other investments | 41 | 40 | ||||||||||||
Investment income, before expense | 650 | 645 | ||||||||||||
Investment expense | ||||||||||||||
Investee level expenses | (17) | (16) | ||||||||||||
Securities lending expense | (21) | — | ||||||||||||
Operating costs and expenses | (37) | (35) | ||||||||||||
Total investment expense | (75) | (51) | ||||||||||||
Net investment income | $ | 575 | $ | 594 | ||||||||||
Property-Liability | $ | 509 | $ | 558 | ||||||||||
Protection Services | 16 | 9 | ||||||||||||
Allstate Health and Benefits | 19 | 17 | ||||||||||||
Corporate and Other | 31 | 10 | ||||||||||||
Net investment income | $ | 575 | $ | 594 | ||||||||||
Market-based | $ | 508 | $ | 325 | ||||||||||
Performance-based | 142 | 320 | ||||||||||||
Investment income, before expense | $ | 650 | $ | 645 |
Performance-based investment income | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Private equity | $ | 105 | $ | 248 | ||||||||||
Real estate | 37 | 72 | ||||||||||||
Total performance-based income before investee level expenses | $ | 142 | $ | 320 | ||||||||||
Investee level expenses (1) | (16) | (14) | ||||||||||||
Total performance-based income | $ | 126 | $ | 306 |
Components of net gains (losses) on investments and derivatives and the related tax effect | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Sales | $ | (120) | $ | (127) | ||||||||||
Credit losses | (12) | (11) | ||||||||||||
Valuation change of equity investments - appreciation (decline): | ||||||||||||||
Equity securities | 148 | (285) | ||||||||||||
Equity fund investments in fixed income securities | 19 | (62) | ||||||||||||
Limited partnerships (1) | 31 | (100) | ||||||||||||
Total valuation of equity investments | 198 | (447) | ||||||||||||
Valuation change and settlements of derivatives | (52) | 318 | ||||||||||||
Net gains (losses) on investments and derivatives, pre-tax | 14 | (267) | ||||||||||||
Income tax (expense) benefit | (6) | 56 | ||||||||||||
Net gains (losses) on investments and derivatives, after-tax | $ | 8 | $ | (211) | ||||||||||
Property-Liability | $ | 6 | $ | (161) | ||||||||||
Protection Services | (1) | (10) | ||||||||||||
Allstate Health and Benefits | 2 | (5) | ||||||||||||
Corporate and Other | 1 | (35) | ||||||||||||
Net gains (losses) on investments and derivatives, after-tax | $ | 8 | $ | (211) | ||||||||||
Market-based | $ | (3) | $ | (304) | ||||||||||
Performance-based | 17 | 37 | ||||||||||||
Net gains (losses) on investments and derivatives, pre-tax | $ | 14 | $ | (267) |
Net gains (losses) on performance-based investments and derivatives | ||||||||||||||
Three months ended March 31, | ||||||||||||||
($ in millions) | 2023 | 2022 | ||||||||||||
Sales | $ | 8 | $ | 23 | ||||||||||
Credit losses | (3) | (4) | ||||||||||||
Valuation change of equity investments | 19 | 11 | ||||||||||||
Valuation change and settlements of derivatives | (7) | 7 | ||||||||||||
Total performance-based | $ | 17 | $ | 37 | ||||||||||
Capital resources | ||||||||||||||
($ in millions) | March 31, 2023 | December 31, 2022 | ||||||||||||
Preferred stock, common stock, treasury stock, retained income and other shareholders’ equity items | $ | 19,167 | $ | 19,880 | ||||||||||
Accumulated other comprehensive loss | (1,673) | (2,392) | ||||||||||||
Total Allstate shareholders’ equity | 17,494 | 17,488 | ||||||||||||
Debt | 8,452 | 7,964 | ||||||||||||
Total capital resources | $ | 25,946 | $ | 25,452 | ||||||||||
Ratio of debt to Allstate shareholders’ equity | 48.3 | % | 45.5 | % | ||||||||||
Ratio of debt to capital resources | 32.6 | 31.3 | ||||||||||||
Period | Total number of shares (or units) purchased (1) | Average price paid per share (or unit) | Total number of shares (or units) purchased as part of publicly announced plans or programs (2) | Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs (3) | ||||||||||||||||||||||
January 1, 2023 - January 31, 2023 | ||||||||||||||||||||||||||
Open Market Purchases | 375,573 | $ | 133.03 | 375,100 | ||||||||||||||||||||||
February 1, 2023 - February 28, 2023 | ||||||||||||||||||||||||||
Open Market Purchases | 538,124 | $ | 134.02 | 339,286 | ||||||||||||||||||||||
March 1, 2023 - March 31, 2023 | ||||||||||||||||||||||||||
Open Market Purchases | 518,483 | $ | 114.65 | 508,120 | ||||||||||||||||||||||
Total | 1,432,180 | $ | 126.75 | 1,222,506 | $ | 649 | million |
Incorporated by Reference | ||||||||||||||||||||
Exhibit Number | Exhibit Description | Form | File Number | Exhibit | Filing Date | Filed or Furnished Herewith | ||||||||||||||
3.1 | 8-K | 1-11840 | 3(i) | May 23, 2012 | ||||||||||||||||
3.2 | 8-K | 1-11840 | 3.1 | November 19, 2015 | ||||||||||||||||
3.3 | 8-K | 1-11840 | 3.1 | August 5, 2019 | ||||||||||||||||
3.4 | 8-K | 1-11840 | 3.1 | November 8, 2019 | ||||||||||||||||
3.5 | 10-K | 1-11840 | 3.6 | February 21, 2020 | ||||||||||||||||
3.6 | X | |||||||||||||||||||
4 | The Allstate Corporation hereby agrees to furnish to the Commission, upon request, the instruments defining the rights of holders of each issue of long-term debt of it and its consolidated subsidiaries | |||||||||||||||||||
10.1 | X | |||||||||||||||||||
15 | X | |||||||||||||||||||
31(i) | X | |||||||||||||||||||
31(i) | X | |||||||||||||||||||
32 | X | |||||||||||||||||||
101.INS | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | X | ||||||||||||||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document | X | ||||||||||||||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||||||||||||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | X | ||||||||||||||||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | X | ||||||||||||||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | X | ||||||||||||||||||
104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) | X |
The Allstate Corporation | ||||||||
(Registrant) | ||||||||
May 3, 2023 | By | /s/ John C. Pintozzi | ||||||
John C. Pintozzi | ||||||||
Senior Vice President, Controller and Chief Accounting Officer | ||||||||
(Authorized Signatory and Principal Accounting Officer) |
March 11, 2022 Mr. Robert Toohey Address on file with the Company Dear Bob, On behalf of the Allstate Insurance Company, I am pleased to officially extend an offer for you to join us as Executive Vice President, Chief Human Resources Officer. We are enthusiastic about the prospect of you joining the Allstate team and are confident that your career with us will be exciting and rewarding. We hope that your response is favorable and look forward to a reply by March 16, 2022. The terms and conditions of this offer are briefly outlined below and are subject to final Allstate Board approval. Base Salary Your annualized base salary will be $625,000 ($24,038.46 will be paid bi-weekly). Subsequent increases in base salary, generally awarded on an annual basis in March, will be dependent on enterprise-wide guidelines and your performance. You will be eligible for a merit increase beginning in March 2023. Cash and Equity Incentive Compensation Cash: You will be eligible to participate in the Annual Incentive Plan (AIP). Your target incentive opportunity is 90% of your base salary. If the maximum corporate and business unit performance level is achieved, the maximum incentive funding is 180%. Please keep in mind the annual incentive award is 100% discretionary and your individual award may be higher or lower based on your individual performance and leader discretion. For 2022, your annual incentive award will be pro-rated based on your hire date and payable in March of 2023. Annual cash incentive awards, if any, are payable in March of the year following the performance period. Equity: Your target equity opportunity is 225% of your base salary. This award will be granted 60% in performance stock awards (PSA) and 40% in stock options, beginning with the February 2023 annual grant. Equity awards are generally granted annually, with manager discretion and with the approval of the Board. Equity Sign-on Award: You will be eligible to receive a one-time equity sign-on award of $2.1 million to be granted on the third business day of the month following hire date. This award will be delivered as follows: •$1,000,000 in restricted stock units, which will vest one third on each of the first, second, and third anniversaries of the grant date. In addition, the restricted stock units accumulate quarterly dividend equivalents in cash payable upon vesting. •$600,000 in performance stock awards that are earned will convert into shares of Allstate stock on the third anniversary of the grant date. In addition, PSA accumulate quarterly dividend equivalents in cash payable upon vesting. •$500,000 in stock options, which have a ten-year term and vest one third on each of the first, second, and third anniversaries of the grant date. |
Restrictive Covenants – Allstate Compensation Plans Non-Solicitation: Your annual cash incentive and equity awards are subject to certain non-solicitation provisions which generally provide, that while employed and for one year after the date of termination, a participant who has received an award cannot solicit Allstate’s employees, agents, customers, or suppliers. Violation of the non-solicitation provisions may lead to the cancellation of awards or recovery of the proceeds received from awards. Non-Competition: Your equity awards also are subject to certain non-competition provisions. The non-competition restrictions generally provide, that for one year following the date of termination, the participant agrees not to engage in, own or control an interest in, or act as principal, director, officer, or employee of, or consultant to, any firm or company that is a competitive business. Violation of the non-competition provisions may lead to the cancellation of awards. Incentive Compensation Clawback: Compensation earned through equity grants and the Annual Executive Incentive Plan is subject to clawback for all Executive Vice Presidents under the following scenarios, subject to discretion by the Compensation & Human Capital Committee of the Allstate Board of Directors: •Material financial restatement, regardless of fraud and; •Termination due to violation of code of conduct resulting in material adverse economic or material reputational impact to Allstate. Restrictive Covenants and Other Obligations Arising from Prior Employment: Allstate expects its employees to comply with the terms of any restrictive covenants and other obligations, including but not limited to non-solicitation and confidentiality provisions, to which they may be subject as a result of any former employment relationships. By signing this letter, you represent that any such covenant or obligation to which you may be subject is not an impediment to accepting employment with, or performing services for, Allstate. In your position with your prior company, you may have been exposed to confidential information and trade secrets. In the event that you come to work at Allstate, we would expect that you would not disclose or use any of that information in your position here. To the extent you are subject to any restrictive covenants or other obligations from prior employment relationships, we advise you to seek the advice of counsel prior to accepting employment with Allstate. Allstate’s Drug Free Workplace Policy: Allstate adheres to a Drug Free Workplace policy. To maintain a drug-free work environment, employees are prohibited from consuming or possessing unauthorized intoxicants or controlled substances, including medically prescribed marijuana, while conducting Company business or while on Company premises. Mutual Arbitration Agreement: As a condition of your employment with Allstate, read, sign, and agree to the terms of the Mutual Arbitration Agreement. You will receive an email from HRComply@allstate.com, which will include a link to the documentation. |
Intellectual Property Assignment Agreement: As a condition of your employment with Allstate, read, sign, and agree to the terms of the Intellectual Property Assignment Agreement. You will be given access to this and other important documents through the Allstate Onboarding Portal. You will receive an email with the link to the Allstate Onboarding Portal once you have satisfied the background and drug screen requirement. Please complete all documentation prior to your start date. Relocation Assistance: You will be provided an optional relocation package and will have 12 months from your date of hire to relocate. Accompanying this letter is a summary of the package. Also available to you is a consultation with a relocation representative who can provide further details of the relocation assistance benefits. Vacation and Holidays: In addition to your salary, Allstate provides both a Comprehensive Total Rewards Benefits Program and Paid Time Off (PTO) Bank. Your PTO bank of 25 days will be prorated during the first calendar year, based on start date. This PTO bank is in addition to company paid holidays. Your PTO Bank can be used for vacation, personal days, family illness and illness days not covered by the Short-Term Disability (STD) plan. Benefits: You are eligible to participate in the medical plan on your first day of employment. Coverage under the medical plan is not subject to pre-existing limitations. Please visit www.allstategoodlife.com to review specific benefits information (“New to Allstate?” and “Benefits Overview” tabs). Executive Perquisite: You will receive the following perquisites: •Annual perquisite allowance of $13,560 ($521.54 per bi-weekly payment). •Financial planning services, provided by a vendor of your choice, will be reimbursed by Allstate for up to $10,000 annually. 401(k) and Pension Benefits: You will be automatically enrolled in the Allstate 401(k) Savings Plan unless you decline enrollment as provided in the plan. You can make pre-tax, Roth 401(k) and/or after-tax deposits to your account. The maximum company match is 4% of your eligible pay if you contribute at least 6% of your eligible pay. The Allstate Retirement Plan provides you a cash balance pension benefit based on pay credits and interest credits. You will become eligible for the Plan upon completing one year of service, after which you will receive retroactive pay credits back to your date of hire. Pay credits are based on your compensation and years of service. Under our current policy, the 401(k) benefit vests after two years of service and the pension benefit vests after three years of service. Please note that you are always fully vested in your contributions to the Allstate 401(k) Savings Plan, including any rollover funds. All compensation and benefit programs are subject to future modifications. Should you accept our offer, we will agree to a mutually acceptable start date of no later than March 28, 2022. To confirm your acceptance of this offer of employment with Allstate subject to its policies and the terms and conditions of its compensation and benefit plans, please complete the eSignature and date from the eSignature version of your letter. |
Sincerely, /s/ Rhonda Ferguson Rhonda Ferguson EVP, Chief Legal Officer, General Counsel & Secretary Chief Human Resources Officer (interim) ACCEPTED & AGREED: Name: Bob Toohey Signature: /s/ Robert Toohey Date: March 12, 2022 |
Form S-3 Registration Statement Nos. | Form S-8 Registration Statement Nos. | ||||
333-255698 | 333-04919 | ||||
333-40283 | |||||
333-134243 | |||||
333-175526 | |||||
333-188821 | |||||
333-200390 | |||||
333-218343 | |||||
333-228490 | |||||
333-228491 | |||||
333-228492 | |||||
333-231753 |
Certifications | Exhibit 31 (i) |
/s/ Thomas J. Wilson | ||
Thomas J. Wilson | ||
Chairman of the Board, President and Chief Executive Officer |
Certifications | Exhibit 31 (i) |
/s/ Jesse E. Merten | ||
Jesse E. Merten | ||
Executive Vice President and Chief Financial Officer |
/s/ Thomas J. Wilson | ||
Thomas J. Wilson | ||
Chairman of the Board, President and Chief Executive Officer | ||
/s/ Jesse E. Merten | ||
Jesse E. Merten | ||
Executive Vice President and Chief Financial Officer |